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The objective is to empirically quantify the concordance between the inverse of Hazard 
Rate Ratio (HRR) and the Median Ratio (MR) in survival studies published in the New 
England Journal of Medicine. 120 pairs of HRR-MR measures were collected in 58 





The measure most used to report treatment effects in survival studies is the Hazard Rate 
Ratio (HRR). Patients should be able to make decisions about interventions based on 
information provided by a health expert. However, the medical literature is replete with 
erroneous interpretations of the HRR which threatens the decision-making process. 
When confronted with a treatment which may affect a patient's longevity, the most 
fundamental question that both patients and doctors must face is: Which option would 
allow me to live longer? But HRR evaluates differences based on the proportions of 
survivors. Instead, the ratio of two survival medians (MR: Median Ratio) allows the 
comparison of times to event. 
The ultimate goal is to improve the readability of the survival studies. Mainly, we focus 
on determining the relationship of the HRR with the MR. The specific objective is to 
empirically quantify the concordance between the inverse of HRR and MR in survival 
studies published in the New England Journal of Medicine (NEJM). 
A post-hoc objective of this work is to evaluate whether there is a trend to publish 
clinical trials that have a more pronounced HRR effect than MR. 
 
Methods 
In the first part of the work, theoretical relationships between HRR and other measures 
such as MR and the Expected mean Ratio were studied. Moreover, we sought via 
simulations relationships between HRR and frequency measures such as Relative Risk 
  
 
(RR), the Odds Ratio (OR) or Risk Difference (RD). Finally, the connection between 
HRR and the Area Under ROC Curve (AUC) was explained. 
We conducted a literature search of survival studies published in the NEJM that 
reported HRR and the medians of both treatment groups. In summary, we have chosen 
survival Randomized Clinical Trials (RCTs) published in the last decade, reporting the 
HRR and the median time of Overall Survival (OS) and/or Progression Free Survival 
(PFS) outcomes. 
All HRR-1 (inverse of the HRR) of the studies have been standardized so that they are 
less than 1. That is, all those HRR-1 with values greater than 1 and its corresponding 
MR were inverted. 
In these papers, the concordance between both measures was assessed with Lin's 
coefficient and the Bland-Altman graphic. The publication bias was evaluated with a 
metaregression and a funnel plot. 
 
Results 
There is a theoretical equivalence between the HRR-1 and the MR in the Exponential 
distribution when the proportional hazard assumption is met. This equality does not 
remain in the Gompertz distribution. 
With regard to the literature search, 58 articles were found with 120 HRR and MR 
measures that met the eligibility criteria. Since 21 (17.5%) median pairs were not 
reported in the text, they were obtained by visual estimation of the survival curves.  
20.7% of papers (12/58) came from 2007 and 74.1% of them had at least two measures 
(43/58). With regard to the outcomes, 65.8% (79/120) were the primary endpoint and 
exactly half of them referred to OS and to PFS. The mean sample size of the collected 
studies was 537 (SD = 336) and the mean number of events was 389 (228). The 
outcome Log HRR-1 has a mean of -0.369 (equivalent to HRR-1 of 0.69) with an SD = 
0.30. The outcome Log MR had a mean of -0.338 (equivalent to MR of 0.71) with an 
SD = 0.27. 
In 116 of 120 pairs of measures (96.7%, CI95%: 91.2 to 99.0) the HRR and the MR aim 
in the same direction as the treatment effect. The estimation of the paired difference 
  
 
between the Log MR and Log HRR-1 weighted by the inverse squared Standard Error 
(SE) of the Log HRR was 0.004, CI95%: -0.051 to 0.059. 
The weighted Linn coefficient for Log MR and Log HRR-1 is 0.67, CI95%: 0.57 to 0.77, a 
fair concordance.  
There is no trend toward publishing studies with a greater HRR effect than MR effect 




This project attempts to relate HRR to MR for supposedly better readability. 
Empirically, it was observed that there is an almost perfect concordance on average, but 
this is not so clear at the individual level. The CIs for the individual measures indicate 
that 95% of observed MRs are within the interval of 65% above and 48% below the 
HRR-1. This difference is too great to considerer that MR and HRR-1 are 
interchangeable. About the qualitative concordance, only a 3.3% of the pairs MR - 
HRR-1 have a disagreement in the direction of treatment efficacy.  
A possible explanation for these discrepancies could be the use of adjusted HRR –the 
unadjusted was available only in 16 of the 120 measurements (13.3%). A sensitivity 
analysis using the available unadjusted HRR showed a higher concordance (Lin's 
coefficient: 0.78). 










AUC: Area Under ROC Curve 
CI: Confidence interval 
DEFF: Design Effect 
ER: Expected mean Ratio 
HRR: Hazard Rate Ratio 
ICC: Intraclass Correlation Coefficient 
LL: Lower Limit of a confidence interval 
MR: Median Ratio 
NEJM: New England Journal of Medicine 
NNT: Number Needed to Treat 
OR: Odds Ratio 
OS: Overall Survival 
PFS: Progression Free Survival 
RCT: Randomized Clinical Trial 
RD: Risk Difference 
ROC: Receiver Operating Characteristic 
RR: Relative Risk 
SE: Standard Error 





Subscript 0: Refers to control group 
Subscript 1: Refers to treated group 
f. density function 
F: distribution function 
λ: hazard function 
Λ: cumulative hazard function 
S: Survival function 
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When confronted with treatments that could have repercussions on longevity, the most important 
question that both doctor and patient must face is:  
Which option would allow me to live longer? 
In order to quantify a reliable answer to this question, it is necessary to find a reliable means of 
measuring outcomes of the various treatments at hand. The specific terminology for what is being 
measured is described as time to an event and one of the most employed effect measures is the 
Hazard Rate Ratio (HRR). The hazard rate at time t is the conditional probability of failure, 
conditional upon survival up to time t1. Expressed mathematically: 
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It describes the relative risk of some undesired event based on the comparison of event rates. 
Despite this specific definition, there is widespread confusion among clinicians and statisticians 
over its interpretation. For example, a first common mistake is to interpret the hazard rate as a 
Relative Risk ratio2 (RR). This is just a measure for comparing the event proportion between two 
groups in a fixed time and it is expressed as a ratio of the event proportion up to an arbitrary date 
occurring in the treatment group compared with the control group. In a constant HRR, the RR 
changes over time and this implies that its value can be overstated if an instant with a great 
difference between survival curves is chosen (see Appendix I). In addition, relative risk can lead 
bias if there are different censure patterns in the groups (see section 2.2.2). 
Another misinterpretation of the meaning of the HRR is to handle it as a relative speed of the 
occurrence of an event3. That is, we can find in the literature that an HRR of 2 is identified with 
events that occur in the treatment group twice as fast as those in the control group. We will study 
how far this interpretation can be valid. 
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An informal explanation of HRR equal to 2 in a certain instant of time could be that a patient in the 
treated group is twice as likely to have the next event as one in the control group (assuming that 
neither had the event before). 
There is no single way to estimate the HRR, but certainly the Cox proportional hazards model is the 
most widespread. The model assumes that the risk for any combination of covariate values is 
proportional to the baseline risk and with the same proportionality factor over time: 
     011 |'exp| ZtZZt     ( 3 )
where 0Z

 is the baseline covariate vector, 'ˆ is the model coefficients vector and 


  1'ˆexp Z
  is the 
HRR estimation for an individual with covariates 1Z

. Attention should be paid so that this estimator 
does not depend on time. 
But if the HRR is difficult to interpret, why is it the most used measure in survival studies? Mainly, 
there are two reasons. First, for practical purposes, the HRR is usually only used in cases where it 
can be assumed constant over time and in these cases the effect of an intervention (or the 
relationship with a covariate) can be summarized in a single value with its uncertainty. Secondly, 
the Cox model provides an estimator with good statistical properties4: 
1. The ˆ  estimation obtained in the regression consistently estimates the vector of parameters β. 
2. Because the estimation was made through partial likelihood, the asymptotic distribution of the 
statistic is Normal with a mean equal to the vector of the parameters and a variance equal to the 
inverse of the Fisher information matrix. This is useful for calculating CIs for the HRR. 
3. Because of the semiparametric nature of this model, the baseline risk can take any form. 
However, the HRR estimation through the Cox model is not completely efficient in the sense that it 
does not achieve the Cramer-Rao bound. 
In this document, we will see that under certain distributions, especially the Exponential, there is an 
analytic relationship between HRR and other measures. The trouble is that most survival times in 
medical studies do not fit to this distribution (Appendix II summarizes the most common shapes for 
the hazard function in medical studies and if the proportionality assumption holds in these 
situations). However, sample size calculations in the follow-up studies may assume further strong 
premises, such as a constant hazard rate in order to use the ratio of medians to find the "n"5. If this 




Several studies have attempted to establish a relationship between HRR and other indicators. 
Moser et al. summarize the statistical techniques used in survival analysis6. There are two main 
types of measures: those that concern the time to the event occurrence (e.g. survival median time) 
and those that refer to the number of patients that experienced the event before a given time, (e.g., 
hazard rate). Both kinds of measures have limitations. For survival hazard rates to be useful, an 
instant of time has to be agreed on as having clinical interest (or alternatively, to make the 
assumption that it is constant). On the other hand, median survival may be highly deceptive; for 
example, in a published clinical trial7, a difference in medians of 3 years corresponded to a 
reduction in risk of only 6.3% over 5 years. 
Michiels et al. showed the relationship between HRR, Odds Ratio (OR) and MR when performing 
meta-analysis on survival studies8. Their conclusion was that these latter two outcomes are not a 
reasonable surrogate of the HRR: the MR and the OR provide, respectively, under- and 
overestimations of the treatment effect. In addition, 20% (25/128) of trials showed opposite 
directions of MR and HRR. That is, whereas one method suggested that treatment was beneficial, 
the other suggested that it was detrimental. However, table 2 of this study showed discrepancies 
among these measures too small to have neither clinical relevance, nor statistical significance. 
Similarly, Symons et al. went into depth on the interrelationship between HRR, RR and OR, 
indicating that the HRR estimation was always between the values of RR (underestimation of the 
effect) and OR (overestimation of effect)9. Furthermore, 3 factors enlarge those discrepancies: 
longer durations of follow-up, higher occurrence of the event and larger treatment effect. In 
addition, a constant HRR implies that RR, OR and Risk Difference (RD) are not constant over time 
and that those statistics can only be applied to a fixed time (see again appendix I). 
Finally, Moser et al. showed that in the case of proportional hazards, there was a clear relationship 
between HRR and the Area Under the Receiver Operating Characteristic (ROC) Curve (AUC); that 
is, between the HRR and the likelihood that a patient in the treated group had an event before 
another patient in the control group10. This property allows us to relate the Cox model with the 
logistic regression and the Mann-Whitney-Wilcoxon statistic as well as to quantify the HRR in 
terms of prediction uncertainty reduction (proportion of patient pairs correctly classified) 
1.3 Objectives 
The ultimate goal is to improve the readability of the survival studies by providing alternative 
reports on the effect measures in survival studies. Mainly, we focus on determining the theoretical 
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and empirical relationships between the HRR and the MR. The initial hypothesis is that the inverse 
of HRR is a measure that is interchangeable with the MR.  
Secondary objectives address the relationships between HRR and Expected mean Ratio (ER), OR, 
RR, RD and AUC. 
A post-hoc objective of this work was to evaluate whether there was a tendency to publish small 
clinical trials that had a more pronounced effect of the HRR than the MR. 
The case of a single dichotomous factor has been addressed (usually representing an intervention of 
a clinical trial). Furthermore, issues such as interaction or collinearity have not been born in mind. 
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2 Theoretical relationship between HRR and other measures 
2.1 Relationship between HRR, MR and ER 
There is an important conceptual difference between HRR and MR. While the first measures the 
comparative probability of one individual experiencing an event as compared to another individual 
from another group (taking into consideration that they both have lived up to a certain point), the 
second quantifies the gain in lifetime of one group over another. Put sharply, the HRR evaluates 
differences in the vertical axis (changes in proportions of survivors) and the MR takes into account 
the differences in the horizontal axis (comparing times to the event.). 
By analogy with an athletic competition, the HRR would measure the gain in the probability of 
winning and the MR would give the margin of the victory. 
Within the group of common statistical distributions, there are only two that have the property of 
proportional hazard under certain parameters: the Weibull distribution (and the particular case of 
the exponential) and the Gompertz distribution11. In this section, we study the theoretical 
relationship between HRR, MR and ER in these distributions. 
 
2.1.1 Weibull distribution 
In the case that the survival times in two study groups fit to the Weibull distribution and there is a 
constant HRR, the relationship between HRR and MR and between HRR and ER can be found 
analytically through the expressions for the median times and hazards. 
First of all, one must know under what parameter combination the proportional hazard assumption 
is met. We consider the Weibull density function with shape parameter k and scale parameter ρ: 
    kk ttktf    exp)( 1  ( 4 )
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The only way that the HRR does not depend on time is that the shape parameters are the same 
(k1=k0=k). In this case, HRR is constant over time, and its value corresponds to the ratio of scale 
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 ( 9 )
where Γ represents the Gamma function. 
 
Therefore, theoretical MR and ER to the kth power are equivalent to the inverse of theoretical HRR 
when proportionality of risks over time holds in the case of two Weibulls. 
HRR-1 = MRk = ERk ( 10 )
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In the case of the exponential distribution, there is an equivalence between the inverse HRR and 
MR because the shape parameter is 1 in any case and the HRR is the ratio of both rates. 
Unfortunately, as mentioned earlier, the exponential model is unrealistic in most medical 
applications since it assumes a constant hazard. 
2.1.2 Gompertz distribution 
As before, we must find the parameter combination that allows us to meet the proportional hazard 
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Consequently the HRR is: 
 











  ( 13 )
 
As one can observe in expression ( 13 ), a constant HRR can only be obtained if the second  
parameters of both distributions are the same (ρ21 = ρ20 = ρ2). In this case, HRR is constant over 




HRR  ( 14 )
 
As the median does not have a closed analytical expression under some parameters and the mean 
has to be calculated by a numerical integral, these statistics were managed by simulating different 
scenarios for several parameter combinations in the treatment (ρ11 and ρ2) and control (ρ10 and ρ2) 
groups (see in Appendix III the simulation procedure and under what conditions the analytical 
median exists). Figure 1 shows the MR and ER as functions of HRR-1 for 12 different scenarios 
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(each one is represented for a single line). For the same scenario, different values of ρ10 provide 
different HRR-1, MR and ER.   
 
















































ER MR 11  0.5 11  1 11  2
 
Figure 1. MR and ER as a function of HRR-1 in several scenarios. Dotted grey line represents the bisection, the region that 
represents the perfect concordance. 
 
It can be seen that the equivalence between HRR-1, MR and ER does not hold in the Gompertz 
distribution. Also, we can observe that, as the HRR effect increases, correspondence (bisection) 
with both MR and ER declines. Moreover, for lower values of ρ2 (top-left) and higher values of ρ11, 
correspondence increases. In any case, the treatment effect derived from the HRR is larger than the 
one derived from the MR or the ER (a smaller value implies a greater effect). 
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2.2 Relationships between HRR and RR, OR and RD in the reference 
group median 
In some survival studies, a particular moment could be of particular clinical interest. Some statistics 
such as RR, OR or RD are useful for expressing the effect of an intervention at a given time. 
However, it is well known that different patterns of censure in both groups imply biased effect 
estimations. 
In this section, a proposal is put forth for calculating these estimators through HRR; the advantage 
of this method is the robustness to different censure distributions in the groups. 
From the proportional hazards assumption, the relationship between the survival curves can be 
deduced at each instant of time: 










 ( 15 )
where β represents the coefficient of the Cox model; Λ is the cumulative hazard function and S 
represents the survival function. 
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One can use the last two equations to find the median survival time in the treated group from the 
reference distribution and the HRR (or to obtain the reference median survival from the treated 
group survival distribution and the HRR). Figure 2 shows that the median in the treated group is the 
moment at which the survival in the reference distribution is (1/2)1/HRR and, on the other hand, the 
reference median is the time point at which survival in the treated group distribution is (1/2) HRR.  
The interpretation of this result is the following: at the moment Med0, 50% of patients have suffered 





























Figure 2. Blue lines represent the known distribution and grey lines represent the distribution whose median one want to know. 
Left: A way to obtain the median in the treated group from the reference distribution and the estimated HRR. Right: A way to get 
the median in the control group from the distribution of the treated group and the estimated HRR.  
 
In order to have a measure of uncertainty for this estimation, the CI can be obtained directly from 
the CI of the HRR estimation (which in turn is derived from the CI of the coefficient β in the Cox 
proportional hazards model): 
        














 ( 17 )
where Z1-α/2 is the quantile (1 - α/2) of the standard normal distribution. 
It should be noted that this is a confidence interval for the proportion of survivors in the treated 
group on the real reference median (not in its estimation), because the uncertainty in the estimation 
of this median is not being considered. 
2.2.1 Frequency effect measures 
Once survival at any point can be estimated from the HRR, other indicators such as RR, OR and RD 
are easily deduced (see appendix I). 
To illustrate the use of measurements such as the RD, RR or OR, let us suppose a study with 
fictitious data (sections 2.2.1.1, 0 and 2.2.1.3).  
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2.2.1.1 The Risk Difference, RD(Med0) at the median control survival time point 
A proposal for reporting results in survival studies could be based on Table 1, which contains a 
measure of the absolute risk in the median reference group survival. 
 
ˆ   ˆSE  HRR RD(Med0) CI95% (RD (Med0)) NNT (Med0) 
-0.5 0.25 0.61 0.16 0.08 to 0.22 6.25 
Table 1. One proposal for reporting results in survival studies based on the RD. 
 
Assuming that the reference group median was one year, a clinician might say to his/her patient: 
"Look, if you use the standard care, you will have a 50% chance of living more than one year. 
However, if you choose the study treatment, you will have a 66% chance of living more than one 
year with an uncertainty ranging from 58% to 72%". 
That is, the patients in the treated group will have a probability of surviving to the reference median 
from 0.08 to 0.22 higher than in the other group. Graphically, this RD is represented in Figure 3. 
 


















Figure 3. Graphical representation of RD between two groups in the median control survival time. 
 
On the other hand, the Number Needed to Treat (NNT) represents the number of patients who 
should be treated in order to prevent one event. Therefore, a clinician might say to his/her manager: 
"If you give me resources to treat 7 patients, I will avoid 1 event in one year". 
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2.2.1.2 The Odds Ratio, OR(Med0) at the median control survival time point 
Alternative measures that can be considered at this particular point in time are the RR and the OR, 
through construction of the corresponding 2x2 table.  
For example, assuming that there were 100 patients in each group and the same HRR and reference 
median as above, we get Table 2. 
 
 Expected number of survivors 
in Med0 
Expected number of deaths in 
Med0 Total 
Treated group 66 34 100 
Reference group 50 50 100 
Total 116 84 200 
Table 2. Expected number of survivors and deaths in both groups in median control time according to 
survival calculated using HRR. 
 
Therefore, Table 1 can be transformed into Table 3 to report the OR(Med0). 
 
ˆ   ˆSE  HRR OR(Med0)  CI95% (OR (Med0)) 
-0.5 0.25 0.61 1.94 1.10 to 3.43 
Table 3. One option for reporting results in survival studies based on the OR.  
 
Assuming that the reference group median was 1 year, a clinician might say to his patient: "Look, if 
you use the standard care, you will have a 50% chance of living more than a year. However, if you 
choose the study treatment, the odds of living longer increase by 94% with an uncertainty ranging 
from 10% to 243%". 
The odds of surviving to the reference median is 1.94 (CI95%: 1.10 to 3.43) times higher in the 
treated group (Table 3). 
2.2.1.3 The Relative Risk, RR(Med0) at the median control survival time point 
Also, Table 1 can be transformed into Table 4 to report the RR(Med0). 
 
ˆ   ˆSE  HRR RR(Med0)  CI95% (RR (Med0)) 
-0.5 0.25 0.61 1.32 1.04 to 1.68 
Table 4. One option for reporting results in survival studies based on the RR. 
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Assuming that the reference group median was 1 year, a clinician might say to his patient: "Look, if 
you use the standard care, you will have a 50% chance of living more than a year. However, if you 
choose the study treatment, the probability of living longer increases by 32% with an uncertainty 
ranging from 4% to 68%". 
In other words, the probability of surviving to the reference median is 1.32 (CI95%: 1.04 to 1.68) 
times higher in the treated group (Table 4). 
2.2.2 Bias of RR, OR and RD 
As mentioned previously, these crude measures provide biased estimates in the presence of different 
censure patterns in both groups. The main advantage of calculation through the HRR is that it 
avoids this bias. A simulation procedure was defined to illustrate this fact. Box 1 describes it. 
 
1. The theoretical RR, OR and RD in the reference group theoretical median were obtained assuming exponential times in both 
distributions with rates 1 and 0.8 and by applying the formulas of Appendix I with the modeled HRR (0.8). 
2. For each group and each iteration, 50 exponential lifetimes with hazard rates 1 and 0.8 (controls and treated) were generated 
with the R function rexp. 
3. The RR, OR and RD employing the full data in the reference group theoretical median were calculated using the resulting 2x2 
table of survivors/deaths in front of treated/control at that moment. 
4. A uniform censure was generated in order to have a 10% of censure proportion in the control group and a variable censure 
proportion in the treatment group (from 0 to 40% in steps of 2%). See Appendix IV for more detailed information about the 
censure generation procedure. 
5. Employing the available data after applying the censure, the RR, OR and RD on the theoretical reference median were 
calculated. We used the 2x2 table resulting from the survivors/deaths in front of treated/control at that moment. 
6. A Cox proportional hazards model was adjusted to obtain an HRR estimation. 
7. The RR, OR, RD obtained by the HRR estimation were calculated using again the formulas of Appendix I. 
8. Steps 2 to 7 were repeated 500 times.  
9. The RR and OR for a specific censure proportion were estimated from the exponential of the mean logarithm estimations in the 
500 simulations. The RD was the mean of RDs for the 500 values in each censure proportion. 
Box 1. Simulation procedure to assess the bias of the RR, OR and RD with different censure proportion in both groups. 
 
Figure 4, Figure 5 and Figure 6 show, respectively, the comparisons between modeled RR, OR and 
RD and the same measures obtained in three different ways (with uncensored data; with censored 
data through a 2x2 table; and with censored data from the HRR estimation). It can be seen that the 
RR, OR and RD calculated in a 2x2 table with the presence of censures provides biased estimations. 
The bias raised as the proportion of censored observations was more unbalanced in both groups. 
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Censure proportion in treated group
R
R
Theoretical or modeled RR
RR calculated with full data
RR directly calculated with censored data
RR calculated through HRR with censored data
 
Figure 4. Theoretical RR (black) is the ratio of theoretical risks in Med0. RR calculated with full data (red) is the ratio between risks 
over the uncensored exponential times generated with rates 1 and 0.8, respectively, on Med0. RR calculated with censored data 
(green) has been calculated after adding 10% of censures in the control group and a variable censure proportion (x-axis) in the 
treated group. RR based on HRR (blue) has been calculated with the HRR estimated by the Cox model over the censored data. The 
vertical dotted line represents the censure proportion in the control group. 
 






Censure proportion in treated group
O
R
Theoretical or modeled OR
OR calculated with full data
OR directly calculated with censored data
OR calculated through HRR with censored data
 
Figure 5. Theoretical OR (black) is the ratio of theoretical odds in Med0. OR calculated with full data (red) is the ratio between odds 
over the uncensored exponential times generated with rates 1 and 0.8, respectively, on Med0. OR calculated with censored data 
(green) has been calculated after adding 10% of censures in the control group and a variable censure proportion (x-axis) in the 
treated group. OR based on HRR (blue) has been calculated with the HRR estimated by the Cox model over the censored data. The 
vertical dotted line represents the censure proportion in the control group. 
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Censure proportion in treated group
R
D
Theoretical or modeled DR
DR calculated with full data
DR directly calculated with censored data
DR calculated through HRR with censored data
Figure 6. Theoretical RD (black) result from subtracting the theoretical S0(Med0) from the theoretical S1(Med0). RD calculated with 
full data (red) is the difference between S1(Med0) and S0(Med0) in the uncensored exponential times generated with rates 1 and 0.8, 
respectively. RD calculated with censored data (green) is the same quantity but calculated after adding 10% of censures in the control 
group and a variable censure proportion (x-axis) in the treated group. RD based on HRR (blue) is the difference between survivals in 
the reference group median calculated with the HRR estimation from the Cox model using the censored data. The vertical dotted line 
represents the censure proportion in the control group. 
 
2.3 Other relationships with HRR: AUC 
In this section, we study what relationship exists between the HRR and the likelihood that a patient 
of a group suffers an event before the patient of another group. 
2.3.1.1 AUCWMW and AUCHRR  
It must be considered that the hazard is a rate rather than a probability. Note that in the formula ( 1 ) 
the expression to the right of the limit sign gives the ratio of two quantities. The numerator is the 
conditional probability we just discussed. The denominator (Δt) denotes a small time interval. By 
this division, we obtain a probability per unit of time, which is no longer a probability but a rate. In 
particular, the scale for this ratio is not 0 to 1, as for a probability, but rather ranges between 0 and 
infinite, and depends on whether time is measured in days, weeks, months, or years, etc12. 
Despite this fact, Moser et al.9 and later Buyse13 demonstrated that there is a clear relationship 
between HRR and the probability (θ) that a patient in the treated group is alive longer than one in 





 1  ( 18 )
 
The expression ( 18 ) is true in any situation with constant HRR and without censured times. A 
correction to θ based on a modified version of the Wilcoxon statistic should be applied in the case 
of having censure14. At the same time, this probability corresponds to the AUC —and to the 
Wilcoxon-Mann-Whitney (WMW) statistic— employed especially in diagnostic studies as a 
complementary result of the logistic regression to quantify the discrimination power. In section 5, 
we assess the concordance between the AUC calculated in the traditional way (through the WMW 
statistic) and the AUC estimated through the HRR from the Cox model. 
2.3.1.2 HRR is sensitive to order but not to time 
On the other hand, does the HRR not depend on the survival times at all but only on the relative 
order of these times in both groups? In order to answer this question, we will present a pair of 
comparisons of survival times in 2 groups. The aim will be illustrated by an example that the act of 
switching times without changing the original order does not update the HRR estimation. 
Obviously, a lone example only proves the non-equivalence, but serves to conceptualize the 
meaning of HRR. 
Now, we will explain the choice of the time values. Times in the treated group are the same in both 
comparisons and they are 20 integers, equally spaced. Half of the times in the control group in the 
first comparison are inserted within the 10 lower times in the treatment and the other half is fixed to 
the largest integer smaller than the lowest time of the treated group. In the second comparison, the 
first half of the reference times are the same and the second half is set at value 1 (see Table 5). 
Attention should be paid to the fact that relative rank times between two groups are the same in both 
comparisons. 
    
Times 
Treated 10 12 14 16 18 20 22 24 26 28 30 32 34 36 38 40 42 44 46 48
Comparison I 
Control 9 9 9 9 9 9 9 9 9 9 11 13 15 17 19 21 23 25 27 29
Treated 10 12 14 16 18 20 22 24 26 28 30 32 34 36 38 40 42 44 46 48
Comparison II 
Control 1 1 1 1 1 1 1 1 1 1 11 13 15 17 19 21 23 25 27 29
Table 5. Times employed in two comparisons of survival times. Times in the treated group are the same in two cases, while in the 
control group the times with values 9 in the first comparison switch to 1 in the second. 
 
 17
We realize that times constructed in this way do not meet the proportional hazards assumption and 
therefore the Cox model should not be applied. However, the purpose is not to assess whether the 
assumption is verified, but if the estimation changes from one comparison to another. 
We made the 2 comparisons between the 2 groups of survival times. Figure 7 shows the survival 
curves of Kaplan-Meier for these comparisons. Although the time of life gained in the first 
comparison is lower (MR: 4.8 vs. 2.9), the HRR is the same in both cases (0.20 CI95%: 0.09 to 0.44). 
Interestingly, the HRR estimation from the Cox model does not have the transitive property and the 
HRR between both control groups is different than 1 (HRR = 1.18 CI95%: 0.64 to 2.22). 
 























Figure 7. Kaplan-Meier survival curves in two comparisons. 
 
3 Methods for empirical relationship between HRR and MR 
In order to verify whether the analytical relationship between HRR and MR in the Exponential 
distribution was met in published studies, we conducted a literature search of survival studies 
published in the New England Journal of Medicine (NEJM) that reported HRR and the medians of 
the groups. The objective is to empirically quantify the concordance between HRR-1 and MR. In 
these papers, the concordance between both measures was assessed. 
All HRR-1 (inverse of the HRR) of the studies have been standardized so that they were less than 1. 
That is, all those HRR-1 with values greater than 1 and its corresponding MR were inverted. 
The statistical analysis were performed using the R software. 
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3.1 Bibliographical search  
A Bibliographical search in the NEJM was performed with the criteria presented in Table 6 
(Appendix V contains previous exploratory searches). 
 
Search Code Search Machine Journal Where All words Exact sentence Some of the words Year Category
1 NEJM NEJM Text - Median Survival Cox Hazard 2000-2010 Research 
2 NEJM NEJM Text Cancer - Cox Hazard 2000-2010 Research 
Table 6. Bibliographical search criteria. 
 
In summary, we have chosen survival trials published in the NEJM in the last decade, reporting the 
HRR and the median time of Overall Survival (OS) and/or Progression Free Survival (PFS) 
outcomes. The detailed eligibility criteria for the measures and for the studies are in Box 2. 
 
Measures 
1) Eligible survival measures refer either to Overall Survival (OS) or to Progression Free Survival (PFS) in any variant 
(Progression Free, Free Event, Disease Progression, Disease Free, Distant-Disease Free, etc.). Measures such as the duration of 
treatment were not included. 
2) The adjusted or unadjusted HRR with its CI95% are in the paper. If both are reported, adjusted HRR is chosen as a measure for 
analysis. 
3) The median survival time in each group is reported, or alternatively, the survival curves that allow a graphical estimation are 
given. 
4) Measures that are equivalent in the same study but evaluated differently were both included (for example, in one paper, the PFS 
may be considered by a radiological test or by symptomatology). 
5) The measures relating to analysis of subgroups were not included unless the article only examines survival in the subgroups and 
does not make any global analysis (with all patients). 
6) If there was a statistically significant interaction in the Cox proportional hazards model, then the measure was not included. 
 
Articles/studies 
7) The paper was published in the NEJM between January 2000 and December 2010. 
8) Only Randomized Clinical Trials (RCTs) were included. 
9) Studies with more than 2 treatment arms and with more than 2 comparisons were included. 
Box 2. Eligibility criteria for the measures and for the articles/studies. 
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Box 3 shows the collected outcomes. 
 
1) Search code with which the paper was found  
2) Publication year of the article 
3) Title of the paper 
4) RCT (Yes/No) 
5) Outcome category (Primary/Secondary) 
6) Outcome type (OS/PFS) 
7) HRR 
8) Lower Limit (LL) of  CI95%(HRR) 
9) Upper Limit (UL) of CI95%(HRR) 
10) Control group survival median 
11) Treated group survival median 
12) Number of patients in the control group 
13) Number of patients in the treated group 
14) Number of events in the control group (if available) 
15) Number of events in the treated group (if available) 
Box 3. Collected outcomes in bibliographical search. 
 
3.2 Univariate descriptive 
For categorical outcomes (publication year, measures by paper, outcome category and outcome 
type), the number and the percentage for each category are provided. In addition, bar charts are 
made. 
For numerical outcomes (sample size, number of events, Log (HRR-1) and Log (MR)), mean, 
Standard Deviation (SD) and boxplots are reported. 
3.3 Concordance 
3.3.1 Qualitative concordance 
We have estimated a qualitative concordance as the proportion of pairs of measures where MR and 
HRR address the same treatment effect direction. 
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Also, a quantitative assessment of the concordance was performed in three ways (sections 3.3.2, 
3.3.3 and 3.3.4).  
3.3.2 Log (MR) - Log (HRR-1) estimation 
A paired weighted difference between Log (MR) and Log (HRR-1) was estimated. To carry out the 
mean comparison, a linear regression weighted by the inverse of the variance of Log (HRR) was 
performed. The Standard Error (SE) of Log (HRR) was obtained as follows15: 




  ( 19 )
where ULHRR and LLHRR are the upper and lower limit of CI95% for the HRR and Z0.975 is the 
quantile 0.975 of the standard normal. 
In the regression, the response was Log (MR) - Log (HRR-1) and there was no explanatory variable, 
so that the intercept directly provides the estimation of the difference. The CI95% was calculated 
from the SE and assuming normality in the estimator.  
Due to the suspicion that the concordance was similar in measures of the same study, a repeated 
measures analysis was performed. We calculated the Intraclass Correlation Coefficient (ICC) for 
the response variable in studies that reported at least 2 pairs of measures. The ICC was calculated 
using a random effects model which considered the papers as blocks using the R function lme in 
nlme package. Subsequently, we calculated the Design EFFect (DEFF) using the formula: 
ICCmDEFF  )1(1  ( 20 )
where m is the number of measures per study (in our case, m = 2). 
Finally, the previous CI95% was increased by the DEFF. 
3.3.3 Lin's concordance 
The concordance between the Log (MR) and Log (HRR-1) was assessed through Lin's coefficient 







  ( 21 )
 
As population parameters were unknown, the sample estimators formula was employed instead of 
formula ( 21 ): 
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 222 2 yxSS Sr YX XYc 
  ( 22 )
 
All the statistics (means, variances and covariances) displayed in the expression ( 22 ) were 
weighted by the SE of the Log (HRR). The confidence interval for ρc was obtained assuming 
normality in the logarithms of the measures and using the following variance17: 



















 ( 23 )
where n is the number of observations; ρ is the Pearson correlation and u is the location shift 





  ( 24 )
 
As before, the unknown population parameters in ( 23 ) and ( 24 ) were replaced by weighted 
sample estimators. 
Because this could be considered the primary analysis of the study, two sensitivity analyses were 
carried out. The first one consisted of obtaining the concordance by using the unadjusted HRRs. 
The second one tried to estimate the variance of Lin's coefficient through a bootstrap procedure 
with 10,000 simulations rather than analytically. 
3.3.4 Bland-Altman concordance 
The traditional bivariate scatter diagram (MR as a function of HRR-1) is not a good graphical tool 
for assessing the agreement of 2 measures. In this graphic, the points tend to cluster around the 
regression line and it is difficult to observe differences between measures. 
An alternative graphic for this purpose was presented by Bland and Altman18. This plot is a 
graphical technique for assessing the concordance between two measures that aim to evaluate the 
same response. It is constructed representing the differences as a function of the average of the two 
measures. 
The location of points in the diagram allows an interpretation (Figure 8): 
 A uniform cloud of points centered on zero of the y-axis indicates more concordance for smaller 
vertical dispersion to this center.  
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 A uniform cloud of points not centered on zero of the y-axis is an indication of a systematic 
error. 
 A cloud of points increasing or decreasing along the x-axis indicates that the magnitude of the 
difference depends on the response value (therefore, the concordance is poor). 
 Finally, a cloud of points with varying dispersion (usually increasing) along the x-axis indicates 
that the magnitude of the concordance depends on the response value. 
 




















































Figure 8. Examples of Bland-Altman graphic. The interpretation of each plot is summarized in the titles. 
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3.3.5 Concordance by subgroups 
To evaluate the factors that could shrink the concordance subgroup, analyses were made according 
to the outcome type (OS / PFS) and the publication year (≤2005 / > 2005). 
Also, in an exploratory way, we assessed whether the differences between the natural logarithms of 
the measures might depend on the censure proportion or on the total number of events. A bivariant 
graph of these differences in terms of these covariates was performed.  
 
3.4 Publication bias 
A post-hoc objective of this work was to evaluate whether there is a tendency to publish small 
clinical trials that had a more pronounced effect of the HRR than the MR (or vice versa). This issue 
was assessed with a Funnel plot and a metaregression. 
3.4.1 Funnel Plot 
A graphical tool used in the meta-analysis to evaluate this kind of bias is the funnel plot. Usually, it 
is built representing the effect on the horizontal axis (in our case, the x-axis represents the ratio 
between the MR and the HRR) and one of the following measures of accuracy in the vertical axis: 
the sample size, the SE, the inverse of the variance or the inverse of the SE19. 
Unfortunately, none of the above accuracy measures is applicable to our study. The sample size is 
not a good surrogate for the precision of the effect in survival studies (since there are censures and 
the number of events is not reported in many papers). On the other hand, we would like to have an 
SE estimation of Log (MR/HRR-1), but from the information available in the studies only SE of Log 
(HRR) could be obtained. Therefore, in order to draw the funnel plot, the inverse SE of Log (HRR) 
was chosen as a surrogate measure of the inverse SE of Log (MR/HRR-1). Appendix VI exposes 
some unsuccessfully attempts performed to obtain an SE estimation of Log (MR/HRR-1). 
A line in the funnel-plot separating the significant and the non-significant areas for a confidence 
level of 95% was represented using the SE of Log (HRR) and assuming normality20 (we employed 
this SE because of the absence of SE of Log (MR/HRR-1)). 
The CI90% for the individual observations was estimated with a non-parametric bootstrap method. 





m = 20   number of points used in the estimation of each segment of the interval 
r =20   number of points chosen with replacement of the previous m to perform an iteration of the bootstrap 
nboots = 100  number of bootstrap iteration for each segment of the interval 
n = 120   number of measures 
 
Algorithm 
 All measures of the ratios MR/HRR-1 are ranked according to the SE of Log (HRR) from lowest to highest and stored in a list 
(List1). 
For i since 1 to (n – m +1) 
 For j since 1 to nboots  
1. The measures from i to (i + m -1) on the List1 are selected in order to find a CI for these ones. 
2. r of them are chosen with replacement. 
3. The ratios MR/HRR-1 chosen in step 2 are ranked and stored in another list (List2). 
4. The higher integer that is lower than or equal to r/20 and the lowest integer that is higher than or equal to (r- 
r/20) give us the positions in the List2 that provides the lij and lsj values (the jth confidence limits) 
End for 
The mean of the nboots components of li and ls provide the LL and the UL of the CI90% on the average height of the 
pertinent inverse SE (those points of List1 from i to (i+m-1). 
End for 
Remark. Generally, in step 4, for a (1-α) confidence level, the parameter r must be divided by 200α (bearing in mind that for non-
integer values of r/(200α), the exact interval will not be obtained) 
Box 4. Algorithm to calculate the CI90% for the individual data in the funnel plot. 
 
Interpretation 
The value 1 of x-axis represents perfect concordance. Therefore, a remoteness of the geometric 
mean with respect to this value indicates a propensity for a greater effect on one of the two 
measures. Furthermore, if the geometric mean does not match the median, it is a symptom of 
asymmetry that would indicate that when the values of MR are greater than those of the HRR-1 this 
difference is greater than when the values of the HRR-1 are higher than those MR or vice versa. 
There are two kinds of publication bias21. A first form of publication bias occurs when non-
significant results are unlikely to be published (bilateral publication bias). In this case, the funnel 
plot is characterized by a hole in the center of the funnel for small studies. The other type is 
observed when studies with results that point to a non-desired effect are less likely to be published 
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(unilateral publication bias); they are characterized by the absence of one of the two tails in the 
funnel (Figure 9). 
 









0.1 0.2 0.5 1.0 2.0 5.0 10.0
Bilateral publication bias
Effect
0.1 0.2 0.5 1.0 2.0 5.0 10.0
Unilateral publication bias
Effect
Figure 9. Examples for interpretation of funnel-plot. 
 
3.4.2 Metaregression 
Weighted linear metaregression was employed to formally test the unilateral publication bias 
hypothesis. The response outcome is the standardized difference of the logarithm measures: 
SE
HRRLogMRLog )()( 1  ( 25 )
 











The intercept of this regression represents the bias and it has a t-distribution with (n-2) degrees of 
freedom, n being the number of measures. This allows having a bias estimation with its CI22. 
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4 Results of empirical relationship between HRR and MR 
4.1 Bibliographical Search  
Table 7 shows the search criteria results. 
 
Search Code Results Accepted Rejected Repeatedly accepted Repeatedly rejected 
1 70 38 32 - - 
2 348 20 267 37 22 
Table 7. Results of bibliographical search. Results: number of papers returned by the search engine; Repeatedly accepted/rejected: 
papers found in the second search that met/didn’t meet the eligibility criteria and were accepted/rejected in the first search. 
 
In total, 58 articles were found with 120 HRR and MR measures that met the eligibility criteria. 
Thirty-seven of the 38 papers accepted in the first search were also recovered in the second. 
Since 21 (17.5%) median pairs were not reported in the text, they were obtained by visual 
estimation of the survival curves (Appendix VII quantifies how good those estimations are). 
 
4.2 Univariate descriptive 
20.7% of papers (12/58) came from 2007 and 74.1% had at least two measures (43/58). About the 
outcomes, 79/120 (65.8%) were the primary endpoint and exactly half of them referred to OS and to 
PFS (Figure 10). 
The mean sample size of the collected studies was 537 (SD = 336) and the mean numbers of events 
was 389 (228). The outcome Log (HRR-1) has a mean of - 0.369 (equivalent to HRR-1 of 0.69) with 
an SD = 0.30. The outcome Log (MR) has a mean of - 0.338 (equivalent to MR of 0.71) with an SD 

























































































Figure 10. Univariate descriptive for the categorical outcomes: publication year of articles; number of 






































Figure 11. Univariate descriptive for numerical outcomes: sample size of the studies; total number of events per study; Log 
(HRR-1) and Log (MR). 
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    n % 
Publication year 2000 3 5.2 
 2001 4 6.9 
 2002 2 3.4 
 2003 2 3.4 
 2004 9 15.5 
 2005 4 6.9 
 2006 7 12.1 
 2007 12 20.7 
 2008 4 6.9 
 2009 5 8.6 
  2010 6 10.3 
Measures by paper 1 15 25.9 
 2 36 62.1 
 3 4 6.9 
 4 1 1.7 
 5 1 1.7 
  12 1 1.7 
Outcome category Primary 79 65.8 
  Secondary 41 34.2 
Outcome type OS 60 50.0 
  PFS 60 50.0 
 Mean (SD) 
Sample size 537 (336) 
Number of events 389 (228) 
Log (HRR-1) -0.369 (0.30) 
Log (MR) -0.338 (0.27) 
Table 8. Numerical descriptive for main collected outcomes. 
 
4.3 Concordance 
4.3.1 Examples of high and low concordance in Kaplan-Meier survival curves 
The aim here is to illustrate examples of Kaplan-Meier curves (extracted from the articles under 
study) where the concordance between the MR and the HRR-1 is either very high or very low (at the 
same time, this subgroup was subdivided into those cases with a higher HRR-1 effect or higher MR 
effect). Table 9, Table 10 and Table 11 show 3 examples of each type. For each measure, the MR, 





4.3.1.1 High concordance 
Table 9 shows no main feature in the curves with high concordance. 
 
MR = 0.51 
HRR-1 = 0.51 
MR/HRR-1 = 1.00 
PFS 
 
 Events (nº) = NA 
MR = 0.70 
HRR-1 = 0.70 
MR/HRR-1 = 1.00 
OS 
 
Events (nº) = 587 
MR = 0.99 
HRR-1 = 0.99 
MR/HRR-1 = 1.00 
OS 
 
Events (nº) = 296 




4.3.1.2 Low concordance 
Table 10 contains the 3 survival curves with a higher MR effect in respect to the HRR effect 
(MR<<HRR-1). 
 
MR = 0.36 
HRR-1 = 0.71 
MR/HRR-1 = 0.51 
PFS 
 
 Events  = 198 
MR = 0.42 
HRR-1 = 0.75 
MR/HRR-1 = 0.56 
PFS 
 
Events = 194 
MR = 0.50 
HRR-1 = 0.89 
MR/HRR-1 = 0.56 
PFS 
 
Events = 710 
Table 10.Examples of Kaplan Meier survival curves with low concordance between MR and HRR-1 and a higher MR effect. These 
curves correspond to the collected measures with a lower value of MR/HRR-1 (within the studies that reported the curves). It seems 
that the 3 curves show some proportion of patients having the event earlier, but then some stabilization occurs; it appears that patients 
who survive the first period, will not suffer the event. 
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Table 11 contains the 3 survival curves with higher HRR effect respect to the MR effect (HRR-1<< 
MR). 
 
MR = 0.50 
HRR-1 = 0.30 
MR/HRR-1 = 1.67 
PFS 
 
 Events = 218 
MR = 0.68 
HRR-1 = 0.44 
MR/HRR-1 = 1.55 
OS 
 
Events = 112 
MR = 1.00 
HRR-1 = 0.68 
MR/HRR-1 = 1.47 
PFS 
 
Events = 542 
Table 11. Examples of Kaplan Meier survival curves with low concordance between MR and HRR-1 and a higher HRR effect. 
Although it is difficult to check visually if the proportional hazards assumption holds, it seems that what they have in common is that 
the treatment effect is more pronounced in later times. 
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4.3.2 Qualitative concordance 
In 116 of 120 pairs of measures (96.7%, CI95%: 91.2 to 99.0) the HRR and the MR aim in the same 
direction as the treatment effect. That is, MR and HRR-1 are either both less than 1 or both greater 
than 1. 
4.3.3 Log (MR) - Log (HRR-1) estimation 
The estimation of the difference between the Log (MR) and Log (HRR-1) weighted by the inverse of 
the squared SE of the Log (HRR) is: 





   
The estimated ratio between MR and HRR-1 is: 
   
039.1970.0:004.1 %951 toCIHRR
MR   
The CI for the difference at the individual level will depend on the specific SE for any concrete 
study; therefore, to give a common CI at the individual level makes no sense.  
Intraclass Correlation Coefficient 
These CIs should be corrected by the ICC of agreement between measures of PFS and OS for each 
paper. A first assessment of the magnitude of the intraclass correlation concordance is shown in 
Figure 12. 





























Figure 12. Difference in the natural logarithm of the PFS measures as a 
function of the same difference in OS measures. 
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An estimation of ICC obtained by a random effects model is 0.61. This is a very large value 
consistent with Figure 12. The Design Effect (DEFF) is: 
61.11)1(1  ICCICCmDEFF  
Now, the CI for the weighted difference between the Log (MR) and Log (HRR-1) corrected by 
DEFF is: 





   
And the estimation of the ratio between the MR and HRR-1 is: 
   
061.1950.0:004.1 %951 toCIHRR
MR   
 
4.3.4 Lin's concordance 
The weighted Lin coefficient for the HRR-1 and MR logarithms was: 
77.057.0:67.0ˆ %95 toCIc   
Given the lower limit of 0.57, this value can be considered as at least a fair concordance in the 
scale23 of Box 5: 
0.0-0.1   independence 
0.1-0.3   bad  
0.3-0.5   poor 
0.5-0.7   fair 
0.7-0.9    good 
0.9-1.0   almost perfect
Box 5. Scale for Lin's coefficient 
 
Two sensitivity analyses were performed: one concerning the point estimate and another 
uncertainty. The first consisted in finding the Lin coefficient using only the 16 available unadjusted 
HRRs. In this case, the point estimate was 0.78.  
In addition, we estimated the bootstrap CI95% for ρc with the original data (adjusted HRRs) and it 
resulted in a similar range: from 0.53 to 0.80. 
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4.3.5 Bland-Altman concordance 
Figure 13 shows that there is equivalence between the two measures in the average of all studies; 
the weighted mean almost matches the perfect concordance. However, at the individual level, there 
is no equivalence; 95% of the individual MRs are located between an increase of 65% and a 































































Mean +/- 2SD (Data)
Figure 13. Left: Relationship between MR and HRR-1 (standardized to be less than 1). Right: Bland-Altman concordance plots 
discrepancies as function of averages. The size of the dots is proportional to the inverse of the SE of Log (HRR) obtained in the 
studies. The blue lines on the right graph represent the weighted mean (by the inverse of SE) of all observations and this average  2 
SD. 
 
4.3.6 Concordance by subgroups 
The purpose of this section is to determine what factors may influence the concordance between the 
two measures. To this end, the concordances have been evaluated for various subgroups: by the 
outcome type (OS/PFS) and by the publication year (2 groups: before/during 2005 and after 2005). 
Also, we have studied if the censure proportion or the total number of events determines the 
concordance. 
PFS / OS 
A comparison of means between groups of PFS and OS for the variable | Log (MR) - Log (HRR-1) | 
has been made. PFS measures have a greater difference between the two measures than in OS 







OS PFS  
Figure 14. Dots represent the sorted Log (HRR-1) in OS (red) and in PFS (green) on the y axis. 
Segments represent the difference between Log (MR) and Log (HRR-1). 
 
However, no significant differences exist between both groups (the explanation of the discrepancy 
with the Figure 14 is the use of weights in the comparison). The estimation of the difference 
corrected by DEFF is:  












This is equivalent to the following estimate of the ratio without logarithms*: 
































                                                 
* The exponential of the absolute value of the logarithm of a ratio is the same as the maximum between the ratio and its 
inverse. Let's look: 























































Figure 15 shows the Bland-Altman graphic stratified by outcome type. The OS discordance seems 
to be greater for greater effect size. PFS points are generally further away from the perfect 
concordance (in either of the 2 directions) than the OS. 
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Mean +/- 2SD (Data)
Figure 15. Left: Bland-Altman graphic for the measures of OS (red dots). Right: Bland-Altman graphic for the measures of PFS 
(green). The size of the dots is proportional to the inverse SE of Log (HRR) obtained in the studies. The blue lines represent the 
weighted average (by the inverse SE) of the pertinent observations and this average  2 SD. 
 
 
However, despite a trend toward greater divergence in measures of PFS, the weighted OS 
concordance (rc = 0.64) is similar to the PFS concordance (rc = 0.65) due to the highest correlation 
presented in this last group. Calculations of overall and per group concordances are detailed below: 
   
   
































where X represents Log (MR) and Y represents Log (HRR-1). All statistics were weighted by the 
inverse SE of the Log (HRR-1). 
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Before/during or after year 2005 
Figure 16 supports the idea that there are no differences between the measures of older and recent 
studies. 
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Mean +/- 2SD (Data)
Figure 16. Left: Bland-Altman graphic for the study measures previous to 2006 (red dots). Right: Bland-Altman graphic for the 
measures after 2005 (green). The size of the dots is proportional to the inverse SE of Log (HRR) obtained in the studies. The blue 
lines represent the weighted average (by the inverse SE) of the pertinent observations and this average  2 SD. 
 
No significant differences in the means of the | Log (MR) - Log (HRR-1) | depending on whether 
the study is before or after 2005. The estimation of the difference is: 




















Figure 17 shows that neither the censure proportion nor the total number of events seem to 
influence the difference between the measures under study. 
 
































Figure 17. Left: Differences in natural logarithms of MR and HRR-1 as function of the censure proportion (if available). Right: 
Differences in natural logarithms of MR and HRR-1 as function of the number of events (if available). 
 
4.4 Publication bias 
In this section, the tendency to publish small clinical trials with a more pronounced effect of the 
HRR than the MR (or vice versa) was evaluated. 
4.4.1 Funnel-Plot 
Figure 18 shows the Funnel plot of the ratio between MR and HRR-1. 
 Points located on the left of the Funnel-Plot represent those responses with a greater observed 
MR effect than the observed HRR effect and vice versa (note that for greater effects, the value 
of the MR or the HRR-1 is lower). 
 The geometric mean is slightly to the right of the perfect concordance. That is, the HRR-1 effect 
is slightly higher than the MR effect in the collected articles (this is equivalent to HRR-1 having 
smaller values). 
 The mean and median coincide, as a sign of symmetry. 
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 There is a trend of the points for small studies to be located to the right. This could be indicative 
that those survival studies with small sample sizes that have a marked HRR effect compared 
with the MR effect were more published. To confirm this hypothesis, a metaregression was 
performed afterwards. 
 Another less important interpretation of the low presence of points in the bottom of the graphic 
















|log(MR)| > |log(HRR)| |log(MR)| < |log(HRR)




There is no evidence of bias (p = 0.40) to publish studies with an HRR effect more pronounced than 
the MR effect in small studies (large SE). 
 





































D 103.037.01   
where D is the difference between the logarithm of the measures. 
Consequently the point estimation for bias with its CI95% was: 
      
24.149.0:37.0 %95 toCIBias   
Therefore, there is no evidence of publication bias, because it can not be excluded that the 
regression line runs through the origin. 
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5 AUCWMW – AUCHRR concordance by simulation 
In this section, we mainly want to assess the concordance between the AUCHRR based on formula ( 
18 ) and the same probability AUCWMW directly estimated as the proportion of treated-control pairs 
in which the treated patient suffers the event after the patient in the reference group. A simulation 
with uncensored exponential times was performed. Box 6 details the procedure. 
 
A hundred simulations of the following steps were carried out: 
1. Fifty exponential survival times per group were generated with rates 1 and 0.8 (control and treated) using R function rexp. 
2. AUCWMW  was estimated exactly as the proportion of treated-control pairs in which the treated individual lives longer. 
3. AUCHRR  was estimated with formula ( 18 ) using the estimated HRR from the Cox model. 
4. Concordance between two probabilities was assessed with the Lin coefficient and Bland-Altman graphic. 
Box 6. Simulation procedure to assess the concordance between AUCWMW and AUCHRR 
 
Values of AUCWMW ranged from 0.35 to 0.62 with a mean of 0.45 (SD = 0.06). Values of AUCHRR 
ranged from 0.34 to 0.58 with a mean of 0.45 (0.05). It is noteworthy that the expected value is 0.44 
(0.8/1.8). Paired mean difference was: 
  
 0.011to-0.018:003.0 %95CIAUCAUC WMWHRR   
 
Figure 20 shows how strong the concordance is between the two estimators of the probability that 
an event occur earlier in one group than in another. Visually, it appears that the concordance is very 
high; specifically, it is:  
91.081.0:86.0ˆ %95 toCIc   
 
Given the lower limit of 0.81, the concordance can be considered as at least a good concordance. 
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Figure 20. A hundred simulations of two exponentials with parameters 1 and 0.8 (for control and treated group) were employed. 
The sample size in each group was 50 patients. Left: Bivariant plot showing the relationship between the AUCWMW and AUCHRR. 




6.1 Key findings 
This project has attempted to relate HRR to other statistical measures for supposedly better 
readability. 
With regard to MR, we have seen a perfect theoretical concordance with HRR-1 in the Exponential 
distribution. In the measures of the NEJM papers, it was observed that there is a satisfactory 
concordance on average (the CI95% indicates that the ratio between them ranges from 0.95 to 1.06), 
but this is not so clear at the individual level; 95% of observed MRs are within the interval of 65% 
above and 48% below the HRR-1. This difference is too great to consider that MR and HRR-1 are 
interchangeable. About the qualitative concordance, only 3.3% of the pairs MR - HRR-1 have a 
disagreement in the direction of treatment efficacy. Although Figure 18 points toward a trend in 
publishing small studies with a greater HRR effect, the publication bias was not statistically 
significant. 
Also, we have observed a theoretical equivalence between the ER with the HRR-1 (and, therefore, 
with the MR) in the Exponential distribution. 
Assuming the proportional hazards assumption, there is a correspondence between the HRR and the 
AUC. This analytical relationship is met in the absence of censored data and, in the presence of 
censored data, a modified version of the Wilcoxon statistic must to be employed. 
About the frequency measures, if censures are not taken into account, the effect estimations may be 
biased. In contrast, it has been observed that RR, OR and RD estimations based on HRR are 
unbiased in the case of exponential distribution and under different censure patterns. 
6.2 Mechanisms and explanations 
We can find 3 possible explanations for the relatively low empirical concordance found. 
6.2.1 Proportional hazard assumption not met 
Although there are formal statistical tests to assess the proportional hazards assumption, these tests 
are not usually reported in published articles. This fact leads us to suspect that in some cases, the 
premise can not be fulfilled. 
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As an example, we examine the 4 qualitatively discordant pairs of measures. In 3 of these 4 pairs, 
the survival curves of Kaplan-Meier were reported (Figure 21) in the papers. In all of them, the 





Figure 21. Three of the 4 survival curves for the measures in which the MR and HRR point 
to different directions of treatment. 
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6.2.2 Adjusted instead of unadjusted HRR 
Another possible explanation about why greater empirical concordance was not achieved could 
stem from the use of adjusted HRRs in the analysis. The unadjusted HRRs were only available in 
16 of the 120 measurements (13.3%), although reporting guidelines24 advise the communication of 
both adjusted and unadjusted measures. In our specific case, the Lin coefficient increases from 0.67 
to 0.78 when considering the unadjusted HRRs.  
RCTs balance the different prognostic factors between groups and in the general linear model the 
absence of colinearity has the advantage that the adjusted treatment effect matches the unadjusted 
(sum squares decomposition theorem). Instead, this property does not apply to other models based 
on likelihood estimations (such as the Cox proportional hazards). In these situations, there are two 
effect measures: the adjusted or specific effect on the unit and the unadjusted or overall effect on the 
population25. 
 
6.2.3 Discordance due to systematic or random error 
We studied whether the amount of discrepancy observed was due to systematic differences in the 
measures or to random fluctuations. Carrasco et al.16 postulate that low concordance associated with 
high correlation implies a corrigible systematic error (i.e., one measure consistently takes values 
higher or lower than the other, such as in Figure 8 top-right) or a linear relationship between 
measures (Figure 8 bottom-left). If the correlation is too low it could mean that there is no 
concordance at all. That is, the random error is so large that concordance is fully diluted and can not 
be detected. In our case, a correlation between Log (MR) and Log (HRR-1) of 0.68 is not large 
enough to ruling out a relevant random error. 
On the other hand, a simulation explained in Appendix VIII was performed to see what would 
happen if the distributions in the studies had been exponential or Weibull. The aim was to assess the 
observed concordance between HRR-1 and MR in exponential distribution and between HRR-1 and 
MRk in Weibull distribution. We wanted to study the Lin coefficient values in two situations where 
it is known that there is a perfect theoretical equivalence. In addition, we also assessed HRR-1 in 
front of MR in Weibull distribution. 
Table 12 lists the concordances and global standard deviations for all data and for the subgroups of 
OS and PFS in the collected data (empirical distribution) and in simulations of exponential and 
Weibull distributions. The last two columns contain the average of the Lin coefficients and the SDs 




(Lin Average) SD 
Empirical Global 0.67 0.25 
 OS 0.64 0.19 
 PFS 0.65 0.30 
Exponential Global 0.93 0.14 
 OS 0.89 0.11 
 PFS 0.93 0.17 
Weibull Global 0.95 0.14 
(HRR-1 vs MRk) OS 0.91 0.10 
 PFS 0.96 0.18 
Weibull Global 0.70 0.32 
(HRR-1 vs MR) OS 0.61 0.25 
 PFS 0.75 0.37 
Table 12. Observed and simulated concordances and SD. 
 
The simulated concordances are higher to the observed ones when there is theorical concordance, 
but similar when there is not. This result suggests that the discrepancies in the observed data could 
not be due solely to sampling variability. As an additional conclusion, we rule out that neither of 
these ones are the distributions of survival times in the most studies of the NEJM. 
Appendix IX contains the Figure 30, which shows where the lines representing  2 SD would be 
located if the distributions were exponential or Weibull. Moreover, in the same Appendix, there are 
4 simulations of the Bland-Altman graphic for these distributions. In any case, it is apparent that the 
random variability is not the cause of the observed empirical discrepancies. 
6.3 Comparison with other relevant studies 
The study of Michiels et al.8 is the most similar to this work, although the objective was somewhat 
different (focused on meta-analysis). They did not formally assess concordance, but they found 
greater disagreements in the directions of the treatment effect between the HRR and the MR. By 
contrast, the quantitative relationship is very optimistic in the sense that the bivariant diagram of the 
Log (MR) versus Log (HRR) have almost all points close to the bisection. Despite this, in their 
discussion it is stated that the MR is not a reasonable alternative to HRR. 
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6.4 Challenges 
There are some issues for improvement in this work that we will mention below.  
Some questions remain for future research which could be noted. It should be studied if measures 
such as MR, ER, RR, OR, RD and AUC are more interpretable than the HRR for people involved in 
health decisions. A survey for doctors and patients could be conducted about the understanding of 
these measures. 
No empirical study on mean survival was possible because medical papers with censored data do 
not report this information. Nevertheless, the biggest concern for a patient is the lifetime that is 
gained from a particular intervention, and this information is obtained directly through the survival 
means in each group. With the purpose offering an answer in this regard, we recommend future 
research on methods for estimating this statistic in the presence of censored times.  
Finally, for simplicity, many of the simulations in this work are based on exponentially distributed 
times. We are aware that this modeling is not the most suitable to situations under study; for this 
reason, it should be checked that the results are robust in other settings. 
6.5 Generability and conclusions 
The data of this work is taken from a single medical journal. The reason for choosing only one is, 
first, to obtain more homogeneous data and, second, to speed up the data collection. The reason for 
choosing the NEJM is that it provides more results with the search criteria than other journals (for 
example, in 2010, NEJM published 168 RCTs with humans, while BMJ published 128, JAMA 60 
and Annals of Internal Medicine 37) and, in turn, NEJM contained a higher proportion of eligible 
papers. 
It is difficult to know whether the results are extrapolated to other studies of lower quality published 
in other journals. A hypothesis could be that these studies have a worse analysis process and that 
many of them, probably, do not meet the proportional hazards assumption, leading to lower 
concordance.  
Although the MR is not interchangeable with the HRR-1, they can be approximated from each other 
in studies that do not have a very large effect size. In addition, alternative measures to HRR can 
complement the information reported in survival papers. 
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ANNEX I. S1(t), RR, OR and RD en funció del HRR i de la S0(t) 
La Taula 13 mostra com per HRR constants i valors de S0(t) donats, els valors de S1(t), RR, OR i 




























 ( 27 )
 
S1(t)  HRR 
 t (anys) S0(t) 0.9 0.8 0.7 0.6 0.5 
1 0.8 0.82 0.84 0.86 0.87 0.89 
2 0.6 0.63 0.66 0.70 0.74 0.77 
3 0.4 0.44 0.48 0.53 0.58 0.63 
4 0.2 0.23 0.28 0.32 0.38 0.45 
RR(t) HRR 
 t (anys) S0(t) 0.9 0.8 0.7 0.6 0.5 
1 0.8 0.91 0.82 0.72 0.63 0.53 
2 0.6 0.92 0.84 0.75 0.66 0.56 
3 0.4 0.94 0.87 0.79 0.70 0.61 
4 0.2 0.96 0.91 0.84 0.77 0.69 
OR(t) HRR 
 t (anys) S0(t) 0.9 0.8 0.7 0.6 0.5 
1 0.8 0.89 0.78 0.68 0.57 0.47 
2 0.6 0.88 0.76 0.64 0.54 0.44 
3 0.4 0.85 0.72 0.60 0.49 0.39 
4 0.2 0.81 0.66 0.52 0.41 0.31 
RD(t)  HRR 
 t (anys) S0(t) 0.9 0.8 0.7 0.6 0.5 
1 0.8 0.02 0.04 0.06 0.07 0.09 
2 0.6 0.03 0.06 0.10 0.14 0.17 
3 0.4 0.04 0.08 0.13 0.18 0.23 
4 0.2 0.03 0.08 0.12 0.18 0.25 
Taula 13. Per una supervivència basal S0(t) (0.8, 0.6, 0.4 i 0.2) i un HRR (0.9, 0.8, 0.7, 0.6, 0.5) donats, valors de 
S1(t), del RR, del OR i del RD. 
Es pot observar que (1) el RR pren valors superiors al HRR; (2) el OR pren valors inferiors al HRR; 
(3) les diferències es van ampliant a mesura que passa el temps i que el HRR disminueix. 
 50
ANNEX II. Principals distribucions en els estudis de medicina 
Les distribucions dels temps de supervivència es poden classificar segons la forma de la seva funció 
de risc (λ). A continuació citem les formes més usuals i en quines situacions apliquen26. 
1) Funció de risc constant. Correspon a poblacions que no presenten envelliment respecte la 
variable resposta. La distribució que resulta és l'exponencial. És molt inusual i només es podria 
donar en determinats esdeveniments adversos. Per exemple, les hemorràgies digestives després 
de l'administració d'antiinflamatoris es diu que tenen el mateix risc sigui la primera o l'enèsima 
vegada que es prenen. 
2) Funció de risc creixent: Es dóna en poblacions que envelleixen amb el pas del temps per l'edat o 
per desgast. Es pot trobar en l'anàlisi del temps de vida de pacients amb leucèmia que no 
responen al tractament. 
3) Funció de risc decreixent: Correspon a poblacions amb una versemblança de fallada molt 
primerenca. Els individus s'enforteixen amb el pas del temps; es dóna en els pacients després 
d'un trasplantament o a l'inici de la vida de qualsevol persona. 
4) Funció de risc amb forma de banyera: La funció de risc és decreixent a l'inici, constant durant 
un llarg període de temps i creixent al final. Apropiada com a model per a poblacions que es 
segueixen des del naixement. Moltes dades de mortalitat segueixen aquest tipus de corbes ja que 
al principi les morts resulten de les malalties infantils, després la baixa taxa de mortalitat 
s'estabilitza i es segueix un lent procés creixent a causa de l'envelliment de la població. 
5) Funció de risc amb forma de gepa: La funció de risc creix a l'inici i al cap d'un temps comença a 
decréixer. Apropiada com a model per a la supervivència després de cirurgia ja que a l'inici hi 
ha un risc creixent de mort a causa de les infeccions i possibles hemorràgies, i aquest decreix a 
mesura que el pacient es recupera. 
Amb l'objectiu d'aprofundir en el coneixement teòric de certes distribucions, en les següents planes, 
es representen les funcions de densitat (f), de supervivència (S), de risc (λ) i de risc acumulat (Λ) per 
algunes distribucions. En aquells casos que no es compleixi la premissa de riscos proporcionals, a 
més a més, s'ha dibuixat el HRR. 
A la vista d'aquestes funcions, es pot concloure que la premissa de riscos proporcionals es inviable 
comprovar-la visualment a partir de les corbes de f(t) o de S(t), sent més assequible en les corbes de 
riscos i sobretot en la de Λ(t). No obstant, el procediment ortodox per verificar-la és mitjançant un 
anàlisi formal dels residus. 
 51
Exemples de riscos proporcionals 
Exemple 1. Exponencial 
 Distribució Esperança Mediana 
── Exp(λ = 0.7) 1.43 0.99 












































Exemple 2. Exponencial 
 Distribució Esperança Mediana 
── Exp(λ = 0.4) 2.5 1.73 













































Exemple 3. Weibull (Risc creixent) 
 Distribució Esperança Mediana 
── Weibull(k = 1.5, ρ = 3.00) 2.71 2.35 














































Exemple 4. Weibull (Risc decreixent) 
 Distribució Esperança Mediana 
── Weibull(k = 0.85, ρ = 2.12) 2.31 1.38 














































Exemples de riscos no proporcionals 
Exemple 1. Log-logística (Risc amb forma de gepa) 
 Distribució Esperança Mediana 
── Log-logistic(k = 1.5, ρ = 1.63) 2.29 1.63 












































Exemple 2. Log-logística (Riscos amb formes de gepa i decreixent)  
 Distribució Esperança Mediana 
── Log-logistic(k = 1.5, ρ = 1.63) 2.29 1.63 








































Exemple 3. Weibull (Riscos decreixent i creixent) 
 Distribució Esperança Mediana 
── Weibull(k = 1.15, ρ = 1.89) 1.80 1.37 














































ANNEX III. Simulation procedure to generate the Gompertz 
distributions 
Simulation procedure 
Simulation scenarios were defined by all possible combinations of the following parameters: 
 
ρ10: 0.01, 0.02, …, 1.99, 2.00
ρ11: 0.5, 1, 2 
ρ2: 0.5, 1, 2, 10 
 
where ρ10, ρ11 are the first parameter of the Gompertz distribution in the control and treated group 
respectively and ρ2 is the second common parameter to both groups (necessary condition for a 
constant HRR).  
Box 7 contains simulation procedure 
 
For each combination of parameters, the next procedure was carried out: 
1. Generation of 10,000 uncensored survival times for each group with the R function rgompertz of the library eha. Attention 
should be paid to the Gompertz parameterization; it is different from the parameterization presented in this work. 
2. The HRR has been obtained analytically as the ratio of the parameters ρ1 of each group (directly obtained from the expression 
of the hazard rate  texp)t( 21   ) 
3. Median and mean survival times for each group are calculated as the median and mean times on the generated data. 
4. MR and ER are obtained as the ratio between both groups. 
 
Box 7. Simulation procedure to find the relationship between HRR, MR and ER. 
 
Analytic median 
There is a necessary condition for the existence of the Gompertz analytical median: the ratio 




  ( 28 )
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Let's see. 
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For the existence of this median the following condition should be met: 
 































For the different scenarios, the real median was compared with the analytical median. The results 
have been displayed in the Figure 22. 
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Figure 22. Analytic median as function of real median for different parameters combination. Dotted lines represent the equivalence. 
In some cases, the analytic median and median calculated via simulation have considerabe differences (see graphics on top). 
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ANNEX IV. Generació de les censures 
El Quadre 8 detalla el procés de generació temps de vida exponencials censurats uniformement i 
amb un temps de reclutament i de seguiment establert. La Figura 23 il·lustra gràficament aquest 
procés. 
 
1) Generació de n1 y n2 temps de vida (T1 y T2) amb distribucions exponencials de paràmetres λ1 i λ2 (mitjançant la instrucció rexp 
implementada en R). 
2) Aplicació de una censura (C) uniforme [0, Tmax] escollint Tmax de manera que la proporció esperada de censures totals sigui 
igual a una proporció (p) nominal donada. Això és,  







S'ha de resoldre l'equació següent per mètodes numèrics per trobar Tmax: 






















3) Addicció d'un temps de reclutament (R) uniforme en [0, t.recluta]. Simplement consisteix en desplaçar l'inici dels temps de vida 
un interval R cap a la dreta.  
4) Addició d'un temps de seguiment (tFollow) que marqui la fi de l'estudi. Aquest temps pot ser fix (tots els temps de vida 
superiors a aquest temps queden censurats) o calculat a partir d'una proporció desitjada de censures per fi d'estudi (es fixa un 
temps de fi de seguiment que censuri la proporció desitjada). 
5) Traslladar tots els temps a un origen comú amb la finalitat de realitzar l'anàlisi. 





Size Control = 10
Size Treated = 10
Lambda Control = 1
Lambda Treated = 0.6
Recruitment time = 0.5
Prop censures Control= 0
Prop censures Treated= 0.2
Prop censures end study(Nominal) = 0.1 ( 0.1 )






Original Times: Exp(0.6) and Exp(1)
Time






Uniform censure in [0,6.6]
Time






Recluitment Time = 0.5
Time






End study time = 2.2
Time








Figura 23. Explicació gràfica del procés de generació de censures. Els 5 gràfics de línees es corresponen als punts 1) a 5) explicats 
en el Quadre 8. 
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La Figura 24 aclareix el comportament dels temps de censura generats en funció del temps de 
seguiment. S'observa que la proporció d'individus censurats, lògicament, creix a mesura que hi ha 
més temps de seguiment.  
 


















0.22 0.35 0.3 0.62 1 NaN
 
Figura 24. Temps de censura (C) en funció dels temps de seguiment (T) generats. Els punts vermells representen els temps del grup 
tractat (major supervivència) i els negres els del grup control. Els punts per sobre de la bisectriu (densos) són els temps observats i 
els situats per sota (buits) són temps censurats. S'observa que la proporció de censures creix a mesura que augmenta el temps de 
seguiment (p.ex., entre els que viuen menys d'una unitat de temps, hi ha un 8% de censures, mentre que en els que viuen entre 4 i 5 
unitats de temps hi ha un 62% de censures). Aquestes dades han estat generats a partir de distribucions exponencials amb taxes de 
mort d'1 i 0.6 respectivament i amb una distribució de censures uniforme en [0, 6.6] que comporten una proporció global de 
censures esperades del 20%. La grandària mostral per grup és de 100 individus. 
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ANNEX V. Cerca bibliogràfica exploratòria.  
En un primer conjunt de cerques exploratòries amb els paràmetres de la Taula 14 es van obtenir un 
total de 135 mesures corresponents a 79 articles de 4 revistes diferents (NEJM, Annals of Internal 
Medicine, JAMA i Lancet). En la recerca final es van descartar revistes diferents al NEJM, en 
algunes per la dificultat d'extreure articles que complissin els criteris d'elegibilitat (Annals of 
Internal Medicine: 2 de 12 elegibles, JAMA: 10 de 51) i per homogeneïtzar els resultats. 
En resum, les cerques consistien en alternar les paraules Cox i Hazard dins del text amb les 
expressions exactes "Median Survival" o diferents tipus de càncer ("Colorectal cancer", "Lung 
cancer", ...) en diferents períodes de 2000 a 2010. 
 
Codi Cercador Revista On Totes les paraules Frase exacta Any Categoria
1 NEJM NEJM Text Cox Median survival 2009 Research 
2 NEJM NEJM Abstract Median Survival Cox - 2008 Research 
3 NEJM NEJM Text Cox Median survival 2008 Research 
4 NEJM NEJM Text Cox Median survival 2007 Research 
5 NEJM NEJM Text Cox Median survival 2006 Research 
6 NEJM NEJM Text Cox Median survival 2005 Research 
7 NEJM NEJM Text Hazard Median survival 2009 Research 
8 NEJM NEJM Text Hazard Median survival 2008 Research 
9 NEJM NEJM Text Cox Median survival 2004 Research 
10 NEJM NEJM Text Cox Median survival 2003 Research 
11 NEJM NEJM Text Cox Median survival 2002 Research 
12 NEJM NEJM Text median Colorectal cancer 2005-2009 Research 
13 NEJM NEJM Text hazard Colorectal cancer 2005-2009 Research 
14 NEJM NEJM Text hazard Lung cancer 2005-2009 Research 
15 NEJM NEJM Text hazard Esophageal cancer 2005-2009 Research 
16 NEJM NEJM Text hazard stomach cancer 2005-2009 Research 
17 NEJM NEJM Text hazard Hepatocarcinoma 2005-2009 Research 
18 NEJM NEJM Text hazard Laryngeal cancer 2005-2009 Research 
19 NEJM NEJM Text hazard Breast cancer 2005-2009 Research 
20 NEJM NEJM Title Chemotherapy followed - 1812- Present Research 
21 NEJM NEJM Abstract Median survival - 2010 Research 
 65
Codi Cercador Revista On Totes les paraules Frase exacta Any Categoria
22 NEJM NEJM Text - Median survival 2010 Research 
23 Google Scholar JAMA Text hazard Median survival 2005-2010 - 
24 Google Scholar JAMA Text hazard trial Median survival 2005-2010 - 
25 Google Scholar Ann Int. Med Text hazard trial Median survival 2005-2010 - 
26 Google Scholar NEJM Text Hazard Median survival 2005-2010 - 
27 Google Scholar NEJM Text Hazard Median survival 2000-2004 - 
28 Google Scholar NEJM Text HR Median survival 2000-2004 - 
29 Google Scholar JAMA Text hazard trial Median survival 2000-2004 - 
30 Google Scholar Ann Int. Med Text hazard trial Median survival 2000-2004 - 
31 Google Scholar LANCET Text hazard trial Median survival 2005-2010 - 
Taula 14. Criteris de cerca temptatius previs a la cerca definitiva. 
 
El nombre de mesures acceptades i rebutjades en cada cerca es pot veure a la Taula 15 (s'ha de tenir 
en compte que les cerques es van realitzar en l'ordre que marca el seu codi, el que implica que 
cerques més tardanes tenien menys opcions de rebutjar o acceptar articles, ja que els articles repetits 
no es van comptabilitzar). 
 
Codi 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31
Acceptats 2 10 0 15 11 9 0 0 5 0 0 0 3 8 0 0 0 0 1 0 0 5 5 4 3 0 11 3 0 0 39
Rebutjats 1 26 0 3 2 1 1 1 3 3 3 2 9 6 0 0 0 0 14 6 5 14 0 6 2 1 10 0 11 5 10
Taula 15. Resultats de la cerca segons el criteri emprat. 
 
Els articles amb zeros a les dues caselles representen cerques que van retornar majoritàriament 








Les cerques anteriors del NEJM poden simplificarse agrupant-les en les categories de la Taula 16. 
 
Codi Cercador Revista On Totes les paraules Frase exacta Any 
2 NEJM NEJM Abstract Median survival Cox  2008 
1, 3, 4, 5, 6, 9, 10, 11 NEJM NEJM Text Cox Median survival 2002 -2009
13 NEJM NEJM Text Hazard Colorectal cancer 2005-2009 
14 NEJM NEJM Text Hazard Lung cancer 2005-2009 
19 NEJM NEJM Text Hazard Breast cancer 2005-2009 
22 NEJM NEJM Text  Median survival 2010 
26,27 Google Scholar NEJM Text Hazard Median survival 2000-2010 
Taula 16. Agrupació dels criteris de cerca realitzats en el NEJM. 
 
Es va provar un segon conjunt de cerques a través del cercador PubMed i del mateix cercador de la 
revista del NEJM (Taula 17 i Taula 18). El que es pot observar és que no aportaven articles nous ja 
que tots els articles acceptats per a l'any 2009 ja havien estat trobats en anteriors cerques. 
 
Cerques provades en PubMed amb paraules clau 
Paraula clau Any 
Trobats 
anteriorment Resultats Rebutjats Acceptats Solapats 
No 
solapats 
Survival Analysis 2009 4 58 54 4 4 0 
Kaplan-Meier Estimates 2009 4 40 36 4 4 0 
Proportional Hazard Models 2009 4 20 18 2 2 0 
Taula 17. Segon conjunt de cerques provades en PubMed. 
 
Cerques provades en NEJM amb paraules en el text 
Paraula clau Any Trobats anteriorment Resultats Rebutjats Acceptats Solapats No solapats 
cox ó hazard ó survival 2009 4 115 111 4 4 0 
Taula 18. Segon conjunt de cerques provades en NEJM. 
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ANNEX VI. Intents d'estimar l'error estàndard del  Log 
(MR/HRR-1) 
En aquest punt es plantegen quatre sistemes d'estimació de la variància del  1/ HRRMRLog  a 
partir de la informació disponible: la variància del Log (HRR-1). 
 
Mètode I: mètode Delta 
Es provarà d'arribar a estimar la variància del Log (MR/HRR-1) a partir de la variància del Log 
(HRR) i de la variància de les medianes usant aproximacions de primer ordre de les sèries de Taylor 
i assumint els estimador com no esbiaixats.  
      






































Malauradament, la majoria d'estudis no comuniquen la variància de les medianes no i per tant, 
aquest mètode no serveix per tenir una estimació. 
 
Mètode II: Empíric 
Consisteix en estimar la variància de forma empírica. Per cada estudi es disposa de la variància del 
Log (HRR). Es dividiran aquestes variàncies en 10 decils i s'agafarà com a representant d'aquest 
decil la mitjana de les variàncies. Per cada decil es calcularà la variabilitat mostral del 
 1/ HRRMRLog . Finalment, es farà una regressió lineal simple, amb aquestes dues variàncies per 
veure si es una es pot predir a partir de l'altra. El procés està més detallat en el Quadre 9. 
 
1. Es divideixen les mesures del MR y del HRR-1 en 10 decils segons la magnitud del EE del Log (HRR) (obtingut en l'article).  
2. Per cada decil es calcula la variància del  1HRR/MRLog . 
3. Es fa una regressió lineal simple amb la variable resposta la variància del  1HRR/MRLog  en funció de la variància del 
Log (HRR-1) escollint como representant de classe la mitjana de totes les variàncies corresponents a aquest decil. 
Quadre 9. Mètode per obtenir una estimació empírica del  1HRR/MRLog  a partir del  HRRLog . 
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La sortida de R de la regressió lineal i el diagrama bivariant corresponent als 10 decils es troben en 
la Figura 25. 
Es pot observar que una variabilitat és difícilment predictible a partir de l'altre. Malgrat el coeficient 
de determinació no és molt baix (R2 = 0.65), en el gràfic s'observa que els decils amb baixa 
variabilitat queden mal predits. Per tant, s'han de buscar altres alternatives. 
 
Coefficients: 
            Estimate Std. Error t value Pr(>|t|)    
(Intercept)  0.02607    0.01019   2.557  0.03381 *  
VLogHRR      0.77780    0.20164   3.857  0.00483 ** 
Residual standard error: 0.02462 on 8 degrees of freedom 
Multiple R-squared: 0.6503,     Adjusted R-squared: 0.6066  
F-statistic: 14.88 on 1 and 8 DF,  p-value: 0.004827 


















Figura 25. Sortida de R de la regressió (a dalt) i diagrama bivariant i recta de regressió (a baix) de 
la variància empírica de l'estimador d'interès en funció de la variància del Log(HRR). 
 
Mètode III: Simulació 
Aprofitant la següent relació teòrica: 
    




















Es pretenia predir mitjançant simulació la variància del Log(MR/HRR-1). El procediment es detalla 
en el Quadre 10. 
 
1. Es van realitzar 50 simulacions de la comparació de 2 mostres de temps de supervivència exponencials. 
2. En cada simulació es van generar 2 paràmetres (λ1 i λ2) per les exponencials d'ambdós grups segons una distribució uniforme 
[1/3 , 1]. Es va usar la funció de R runif. 
3. Per cada grup, es van generar 50 temps de vida exponencials amb paràmetres λ1 i λ2 amb la funció de R rexp.  
4. Per a cada parella de paràmetres es van generar 50 repliques per tal d'estimar la variabilitat tant dels logaritmes del HRR y del 
MR, així com de la covariància d'ambdós.  
5. Es van realitzar dues regressions. La resposta en ambdues va ser la variància del  1HRR/MRLog . En la primera, la 
variable predictora va ser la variància del Log (HRR-1) y en la segona va ser l'expressió: 
Log (HRR-1)-2Cov (Log(HRR-1) , Log (MR)) 
Quadre 10. Procediment de simulació per intentar predir  1HRR/MRLog  en distribucions exponencials. 
 
La Figura 26 conté la sortida de R d'ambdues regressions i els gràfics corresponents. 
Respecte a la primera regressió, el principal problema és que desconeixem si la relació observada en 
un cas molt concret (distribucions exponencials sense censura) seria generalitzable a altres 
situacions i, a més, l'R2 és ínfim (Figura 26). 
En la segona regressió el coeficient de la variable dependent hauria de ser proper a 1 (sabem que el 
valor real és 1) i el terme independent s'interpretaria com la variància del MR. No obstant això, 
aquest terme independent no és constant i invalida la informació que es pugui obtenir, a més no ens 
serveix perquè desconeixem la covariància, que és necessària per establir el predictor. 
 
Residuals: 
      Min        1Q    Median        3Q       Max  
-0.019538 -0.007806  0.001699  0.007072  0.027846  
 
Coefficients: 
             Estimate Std. Error t value Pr(>|t|)     
(Intercept)  0.043420   0.006535   6.644 2.59e-08 *** 
V.LOG.HRRinv 0.015766   0.138343   0.114     0.91     
--- 
 
Residual standard error: 0.009875 on 48 df. 
Mult. R-squared: 0.0002705,  Adj. R-squared: -0.02056  
F-statistic: 0.01299 on 1 and 48 DF,  p-value: 0.9097 
Residuals: 
      Min        1Q    Median        3Q       Max  
-0.019563 -0.007954  0.001624  0.006963  0.027834  
 
Coefficients: 
               Estimate Std. Error t value Pr(>|t|)     
(Intercept)    0.043854  0.004869   9.007 6.93e-12 *** 
VLNMRHRRMIN2COV-0.007045 0.111907  -0.063     0.95     
--- 
 
Residual standard error: 0.009876 on 48 df 
Mult. R-squared: 8.255e-05,  Adj. R-squared: -0.02075  
F-statistic: 0.003963 on 1 and 48 DF,  p-value: 0.95 
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Figura 26. Sortida de R (a dalt) i diagrama bivariant (a baix) corresponents a les dues regressions realitzades. La línia vermella 
correspon a la bisectriu i la línia negra a la recta de regressió. 
 
Mètode IV: A través del nombre d'esdeveniments o de la magnitud del HRR 
L'objectiu d'aquest apartat és determinar si:  
(1) la magnitud del HRR i  
(2) la grandària mostral  
influeixen en les variàncies i correlacions del MR i el HRR. Si es trobés que sí, podria estudiar-se 
en quina manera aquest resultat podria ser útil. El Quadre 11 mostra el procediment emprat. 
 
1. Es van realitzar 50 simulacions de la comparació de 2 mostres de temps de supervivència exponencials. 
2. En cada simulació els paràmetres λ1 i λ2  van ser generats amb sengles distribucions uniformes [1/3, 1]. 
3. Es van generar 50 temps de vida exponencials amb paràmetres λ1 i λ2. 
4. Per cada parell de paràmetres, es van generar 100 rèpliques per estimar la variabilitat tant dels logaritmes del HRR i del MR, 
així com de la correlació entre ambdós.  




La Figura 27 conté la sortida de R de la descriptiva dels estadístics estudiats i els diagrames 
bivariants corresponents a aquests estadístics enfront de la magnitud del HRR. S'observa que la 
magnitud del HRR no afecta a cap dels paràmetres d'estudi. 
 
> summary(varLogMR) 
   Min. 1st Qu.  Median    Mean 3rd Qu.    Max.  
0.05838 0.07965 0.08827 0.08501 0.09410 0.10130  
> summary(varLogHRR) 
   Min. 1st Qu.  Median    Mean 3rd Qu.    Max.  
0.03211 0.04058 0.04584 0.04592 0.04941 0.05926  
> summary(varLogMRHRR) 
   Min. 1st Qu.  Median    Mean 3rd Qu.    Max.  
 0.1573  0.1976  0.2241  0.2175  0.2331  0.2716  
> summary(corLogMRHRR) 
   Min. 1st Qu.  Median    Mean 3rd Qu.    Max.  
-0.7877 -0.7213 -0.6993 -0.6935 -0.6644 -0.6009 































































Figura 27. A dalt: Sortida de R dels estadístics descriptius de les variàncies del MR, del HRR, de la 
variància del seu quocient i de la correlació. A baix: Diagrames bivariants d'aquestes magnituds en 
funció de la magnitud del HRR. 
 
El Quadre 12 mostra el procediment emprat per estudiar com varien aquestes magnituds en funció 
de la grandària mostral. 
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1. Per cada grandària mostral (de 10 a 200 individus per grup en intervals de 5), es va realitzar una simulació de la comparació de 
2 mostres de temps de supervivència exponencials amb paràmetres λ1 = 1 i λ2 = 0.8 (es van mantenir constants atès que ja s'ha 
vist que el HRR no afectava les variàncies estudiades). 
2. Per cada grandària mostral, es van generar 100 rèpliques per estimar la variabilitat tant dels logaritmes del HRR i del MR, així 
com de la correlació entre ambdós.  
Quadre 12. Procediment per esbrinar la influència de grandària mostral en la variabilitat i correlació de les mesures. 
Tot i que la inversa de la variància del logaritme del HRR està directament relacionada amb la 
grandària mostral (Figura 28), no passa el mateix amb la correlació. El que torna a fer inútil aquest 
sistema d'estimació. 
> summary(varLogMR) 
   Min. 1st Qu.  Median    Mean 3rd Qu.    Max.  
0.01750 0.02709 0.04024 0.06662 0.07567 0.42410  
> summary(varLogHRR) 
   Min. 1st Qu.  Median    Mean 3rd Qu.    Max.  
0.00840 0.01305 0.01878 0.03740 0.03690 0.30180  
> summary(varLogMRHRR) 
   Min. 1st Qu.  Median    Mean 3rd Qu.    Max.  
0.04307 0.06613 0.09400 0.17300 0.17650 1.28400  
> summary(corLogMRHRR) 
   Min. 1st Qu.  Median    Mean 3rd Qu.    Max.  
-0.7814 -0.7440 -0.6958 -0.6898 -0.6540 -0.5535 



































































Figura 28. A dalt: sortida de R dels estadístics descriptius de les variàncies del MR, del HRR, 
de la variància del seu quocient i de la correlació. A baix: diagrames bivariants d'aquestes 
magnituds en funció de la grandària mostral. 
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ANNEX VII. Concordança entre les medianes estimades de 
forma gràfica 
En aquells articles que no van comunicar les medianes en el text o en les taules, però que sí que 
donaven les corbes de supervivència estimades per Kaplan i Meier i aquestes assolien la proporció 
de 0.5 en tots els grups, les medianes es van estimar gràficament. 
S'ha comprovat que la concordança entre les estimacions de dos avaluadors emmascarats (als valors 
reals i a l'estimació de l'altre avaluador) i les medianes reals de 14 mesures corresponents a 7 estudis 
és elevada (Figura 29).  
 































Figura 29. Esquerra: Diagrama bivariant de les medianes estimades per l'avaluador I (negre) i l'avaluador II (vermell) enfront de les 
medianes reals. Dreta: Gràfic de Bland-Altman de concordances. 
 
Els coeficients de Lin per cada parella són els següents: 
 
Concordança Avaluador 1 – Mediana Real:  0.998  CI95%: 0.993 a 0.999 
Concordança Avaluador 2 – Mediana Real:  0.993  CI95%: 0.981 a 0.998 
Concordança Avaluador 1 – Avaluador 2:  0.998  CI95%: 0.993 a 0.999 
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ANNEX VIII. Simulation procedure to generate Weibull and 
exponential distributions based on empirical data 
Box 13 cointains the simulation procedure to generate Weibull and exponential data as similar as 




i: group   i = 0, 1 
j: measure number  j = 1, 2, …, 120 
s: simulation number s = 1,2,…, 100 (Not listed in the below table) 
Exponential Weibull 
1. Parameter estimation 
In the exponential distribution, the 
HRR is directly the rate ratio (i.e., the 
ratio of two parameters): 
 
ρ0j = 1 (the jth rate for control group is 
always 1) 
ρ1j = HRRj (the jth rate for treated 
group is the jth HRR) 
 
1. Parameter estimation 
The common shape parameter (k) of both groups and the two scale parameters (ρ0, ρ1) were 
































































 ( 30 ) 
If the shape parameter is negative due to the HRR and MR aim in opposite directions, then 
the measure was excluded from the simulation. 
2. Time generation  
n0j (control group size) y n1j (treated group size) lifetimes of the pertinent distribution were generated employing the R functions 
rexp and rweibull, respectively. 
3. Censure proportion 
If the total number of events in the jth measure was known, the global censure proportion (pj) was equal to 1 minus the ratio of the 
number of events (Ei = E0i + E1i) divided by the number of patients (ni = n0i + n1i) for that measure. If the number of events was not 
available, pj was the average value equal to the total known number of events divided by the total number of patients in studies that 
reported the events. 
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4. Censure generation 
A uniform censure in [0, Tmax] was generated. Tmax was calculated to provide an expected censure proportion equal to pj. (See 
appendix IV) 
5. MR calculation 
Each median was calculated by Kaplan-Meier and their ratio was performed. If a median can not be estimated, the measure is 
removed in this simulation. 
6. HRR calculation 
Calculated by adjusting the Cox model 
Exponential Weibull 
7. Lin concordance coefficient 
The weighted (by the inverse of SE obtained from the Cox 
model) concordance between Log (MR) and Log (HRR-1) was 
calculated with the Lin coefficient. 
7. Lin concordance coefficient 
The weighted (by the inverse of SE obtained from the Cox 
model) concordance between kj·Log (MR) and Log (HRR-1) was 
calculated with the Lin coefficient. 
8. SD 























Box 13. Simulation process in a single iteration to generate exponential and Weibull time distributions similar to empirical data. This 
process was repeated 100 times. 
  
Regarding Weibull simulations, 6.7% (8/120) of the parameters could not be calculated because of 
the negative values of the shape parameters. Between 4.5% (5/112) and 5.4% (6/112) – depending 
on the simulation – of the remaining measures were removed during the simulation because 
medians could not be estimated from Kaplan-Meier survival. Therefore, the final Weibull 
simulations were made with 106 or 107 pairs of measures. The concordance and the SD for each 
distribution were estimated as the average of the Lin coefficients and SDs over the 100 simulations, 
respectively. 
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ANNEX IX. Simulacions del gràfic de Bland-Altman sota les 
distribucions exponencial i Weibull 
La Figura 30 mostra on es situarien las línees de  2 DE en el cas de les dades reals i sota les 
simulacions de la distribució Weibull i Exponencial.  
 






































Mean +/- 2SD (Data)
Mean +/- 2SD (Exp)
Mean +/- 2SD (Weib)
Figura 30. El gràfic de Bland-Altman de concordança de les discrepàncies en funció de les mitjanes. La grandària dels punts és 
proporcional a la inversa de la SE del Log (HRR). Les línies blaves representen la mitjana ponderada (per la inversa de la SE) i 
aquesta mitjana  2 DE. Les línies taronges representen on es trobarien les línies corresponents a  2 DE si totes les distribucions de 
temps fossin exponencials i les línies de color rosa tindrien el mateix significat pel cas de la distribució Weibull. 
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En 4 de les 100 simulacions de les dades dels estudis assumint distribucions exponencials o 
Weibulls, el gràfics de Bland-Altman es van generar amb l'objectiu de veure com quedaven els 
punts distribuïts sota la premissa de concordança teòrica perfecta (Figura 31 i Figura 32). 
 







































Mean +/- 2SD (Data)







































Mean +/- 2SD (Data)






































Mean +/- 2SD (Data)






































Mean +/- 2SD (Data)
Figura 31. Simulació de 4 gràfics de Bland-Altman sota la distribució Exponencial. El coeficients de Lin en els 4 gràfics (d'esquerra a 
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Mean +/- 2SD (Data)
Figura 32. Simulació de 4 gràfics de Bland-Altman sota la distribució Weibull. El coeficients de Lin en els 4 gràfics  (d'esquerra a 
dreta i de dalt a baix) són 0.95, 0.94, 0.96 i 0.94 respectivament. 
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ANNEX X. Scripts en R 
Script 1. Script principal que realitza la lectura de les dades, els gràfics de Bland-Altman, el Funnel-plot, i les figures dels annexos 
VI i VII. 
 
################################################################################ 
# Script per l'anàlisi de les dades NEJM                                       # 
# Autor: Jordi Cotés Martínez                                                  # 
# Data: Maig de 2011                                                           # 










####################### Lectura de les dades ###################################  
setwd('E:\\TFM\\RecercaHRRvsMediana') 
NEJM <- read.csv2('NEJM3.csv',header=TRUE,dec='.') 
 
 
####################### Inspecció de les dades #################################  
head(NEJM) ; names(NEJM) ; dim(NEJM) 
 
 
####################### Seleccionar les variables que ens interesen ############  
columns <-  c("CodeArt","Num","CodiSearch","Year","Outcome","Type","HRR_Adj", 
              "LI_Adj","LS_Adj","MedianC","MedianT","HRR","LI","LS","MedRat", 
              "MR.HRR","GeoMean","N","NC","NT","E","EC","ET") 
 
 
####################### Seleccionar els ECA's ################################## 
selCT <- which(NEJM[,"CT"]=="Yes") 
dades <- NEJM[selCT,columns] 
              
 
####################### Inspecció de les dades  i descriptiva ##################  





###################### Selecció de les dades per l'anàlisi ##################### 
dades2 <- dades 





##                                                                            ## 
##                                                                            ## 
##                                Gràfics                                     ## 
##                                                                            ## 




#                    Grafic 1: Diagrama bivariant                              # 
################################################################################ 
 




##### Grandaria dels punts del gràfic (proporcional al EE del log (HRR)) 
esc <- 8                                      # Paràmetre d'escala per la grandaria dels punts 
EE <- with(dades2,(log(LS)-log(LI))/(2*1.96)) # EE del HRR 
size <- round(1/(esc*EE),2)                   # Grandària dels punts en funció de EE i size 
 
##### Color pels punts dels gràfics 
colOS <- ifelse(dades2$Type=="OS",2,3)         # Color en funció de PFS (verd) o OS (vermell) 
colYear <- ifelse(dades2$Year>2005,2,3)        # Color en funció de <=2005 (verd) o >2005 (vermell) 
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##### Gràfic sense eixos 
HRR <- dades2$HRR 
MR <-  dades2$MedRat 
xymin <- min(HRR,MR) ; xymax <- max(HRR,MR) 
plot(HRR,MR,xlim=c(xymin,xymax),ylim=c(xymin,xymax),pch=1,log='xy',cex=size, 
      xlab=expression(Log~bgroup("(",HRR^-1,")")),ylab="Log (MR)",main="", 
      xaxt="n",yaxt="n",col=1) 
abline(0,1,lty=2)                   # bisectriu 
 





#                                  Gràfic 2: BA                                # 
################################################################################ 
BlandAltman(x=log(dades2$HRR),y=log(dades2$MedRat), 





#                                  Gràfic 2a: BA en subgrup OS                 # 
################################################################################ 
par(mfrow=c(1,2), las=1) 
dadesOS <- subset(dades,dades$Type=="OS") 
EEOS <- with(dadesOS,(log(LS)-log(LI))/(2*1.96))  # EE del HRR 
sizeOS <- round(1/(esc*EEOS),2)                   # Grandària dels punts 
colOS2 <- ifelse(dadesOS$Type=="OS",2,3) 
BlandAltman(x=log(dadesOS$HRR),y=log(dadesOS$MedRat), 





#                                  Gràfic 2b: BA en subgrup PFS                # 
################################################################################ 
dadesPFS <- subset(dades,dades$Type=="PFS") 
EEPFS <- with(dadesPFS,(log(LS)-log(LI))/(2*1.96))  # EE del HRR 
sizePFS <- round(1/(esc*EEPFS),2)                   # Grandària dels punts 






#                                  Gràfic 2c: BA en subgrup <=2005             # 
################################################################################ 
par(mfrow=c(1,2), las=1) 
dadesBefore <- subset(dades,dades$Year<=2005) 
EEBefore <- with(dadesBefore,(log(LS)-log(LI))/(2*1.96))  # EE del HRR 





#                                  Gràfic 2c: BA en subgrup >2005              # 
################################################################################ 
dadesAfter <- subset(dades,dades$Year>2005) 
EEAfter <- with(dadesAfter,(log(LS)-log(LI))/(2*1.96))  # EE del HRR 




















HRR_OS_Sort <- sort(with(dadesOS,log(HRR)))                        # HRR ordenados 
MR_OS_Sort <- with(dadesOS,log(MedRat[order(with(dadesOS,HRR))]))  # MR ordenados 





HRR_PFS_Sort <- sort(with(dadesPFS,log(HRR)))                        # HRR ordenados 
MR_PFS_Sort <- with(dadesPFS,log(MedRat[order(with(dadesPFS,HRR))])) # MR ordenados 






#                                  Gràfic 3: Funnel- Plot                      # 
################################################################################ 
par(mfrow=c(1,1),mar=c(5,6,5,3),las=1) 
ma <- with(dades2,max(MedRat/HRR,HRR/MedRat)) 
plot(dades2$MedRat/dades2$HRR,1/EE,pch=1,xlab=expression(frac(MR,HRR^-1)),ylab=expression(paste("~ 
",frac(1,SE))), 








#                 Gràfic 4: Log(MR/HRR) vs. proporció de censures              # 
################################################################################ 
par(las=1,mar=c(5,6,3,1),mfrow=c(1,2)) 
pCens <- 1- dades2$E/dades2$N 
plot(pCens,log(dades2$MedRat/dades2$HRR),pch=1,xlab='Censure 
proportion',ylab=expression(log~bgroup("(",frac(MR,HRR^-1),")")), 






#                 Gràfic 4: Log(MR/HRR) vs. nombre d'events                    # 
################################################################################ 
par(las=1,mar=c(5,6,3,1)) 
nE <- dades2$E 
plot(nE,log(dades2$MedRat/dades2$HRR),pch=1,xlab='Number of events', 
 ylab=expression(log~bgroup("(",frac(MR,HRR^-1),")")), 











#                                                                              # 
#                                                                              # 
#                                    Anàlisi                                   # 
#                                                                              # 




#                                 Concordança                                  # 
################################################################################ 
 
############################## Qualitativa ##################################### 
### Proporció d'estudis on el HRR y el MR apunten en el mateix sentit  
e <- with(dades2,sum(MedRat>1)) 







################### Quantitativa: Coeficient de Lin ############################ 
Lin1 <- epi.ccc(log(dades2$MedRat),log(dades2$HRR))$rho.c # Sense ponderar 
Lin1bis <- LinWeigth(dades2,size)[1]                      # Sense ponderar (calculat a mà) 
LinPond <- LinWeigth(dades2,size)[2]                      # Ponderant (calculat a mà) 
cat("Coeficiente de Linn (con función de R):",Lin1[[1]], 
 "\nCoeficiente de Linn (calculado a mano):",Lin1bis, 
 "\nCoeficiente de Linn ponderado (calculado a mano):",LinPond,"\n") 
LinInterpretation() 
 
### Subgrup OS 
(LinPondOS <- LinWeigth(dadesOS,sizeOS)[2]) 
 
### Subgrup PFS 
(LinPondPFS <- LinWeigth(dadesPFS,sizePFS)[2]) 
 
########################### Anàlisi de sensibilitat 1 ########################## 
### IC per bootstrap 
nboot <- 10000 
LinPondBoot <- c() 
for (i in 1:nboot){ 
  mostra <- sample(1:n,n,rep=T) 
  LinPondBoot[i] <- LinWeigth(dades2[mostra,],size)[2] 
  print(i) 
} 
sdLin <- sd(LinPondBoot) 
z <- qnorm(0.975) 
LILinPond <- LinPond - z*sdLin 
LSLinPond <- LinPond + z*sdLin 
cat("El intervalo de confianza calculado por bootstrap para el coeficiente de Lin Ponderado es: ", 
    round(LILinPond,2)," to ", round(LSLinPond,2),"\n") 
 
########################### Anàlisi de sensibilitat 2 ########################## 
##### Càlcul del coeficient de Lin pels HRR ajustats 
columns2 <-  c("CodeArt","Num","CodiSearch","Year","Outcome","Type","HRR_Unadj", 
              "LI_Unadj","LS_Unadj","MedianC","MedianT","HRR","LI","LS","MedRat", 
              "MR.HRR","GeoMean","N","NC","NT","E","EC","ET") 
selCT_NA <- which(NEJM[,"CT"]=="Yes" & !is.na(NEJM[,"HRR_Unadj"])) 
dadesUnadj <- NEJM[selCT_NA,columns2] 
dadesUnadj$HRR <- dadesUnadj$HRR_Unadj 
sizeUnadj <- with(dadesUnadj,LS_Unadj-LI_Unadj) 







#         CCI (Intraclass correlation coefficient) para la concordança         # 
################################################################################ 
 
########################### Arreglar les dades ################################# 
##### Convertir les dades en una llista d'articles amb almenys dues mesures 
dades3 <- DataForICC(dades2) 
##### Converteix la llista anterior en una matriu de dues columnes amb les diferències per OS i PFS 
MR_HRRMatrix <- DataForICC2(dades3) 
 
############################## Gràfic ########################################## 
### Paràmetres 
xymin <- min(MR_HRRMatrix) ; xymax <- max(MR_HRRMatrix) 
xy <- max(abs(c(xymin,xymax))) 
labx <- expression(Log~bgroup("(",frac(MR[OS],HRR[OS]^-1),")")) 









########################### ICC ################################################ 
 
### ICC calculat amb funció de R 
ICC1 <- icc(MR_HRRMatrix,model = "twoway",type = "consistency",unit="single", r0 = 0, conf.level = 
0.95) 
 
### ICC calculat amb model d'efectes aleatoris 




#                  Diferències entre les dues mesures                          # 
################################################################################ 
 
##### IC de la diferència ponderada 
logMRHRR <- log(dades2$MedRat)-log(dades2$HRR) 
mod.lm <- lm(logMRHRR~1,weights= 1/(EE^2)) 
EstRatio2 <- coef(mod.lm) 
EEglobal <- coef(summary(mod.lm))[2] 
CI <- confint(mod.lm) 
est <- mod.lm[[1]] 
cat("Diferencia entre el logaritmo de MR y el logaritmo HRRinv ponderada es:" 
 ,round(est,3),"[",round(CI[1],3),",",round(CI[2],3), 
    "]\nCociente de MR y HRRinv ponderado 
  es:",round(exp(est),3),"[",round(exp(CI[1]),3),",",round(exp(CI[2]),3),"]\n") 
 
##### IC de la diferència ponderada i corregida pel DEFF 
DEFF <- 1+ICC 
amplitud <- DEFF*(CI[2]-est) 
CI2 <- c() 
CI2[1] <- est-amplitud 
CI2[2] <- est+amplitud 
cat("Diferencia entre el logaritmo de MR y el logaritmo HRRinv ponderada 
  es:",round(est,3),"[",round(CI2[1],3),",",round(CI2[2],3), 
    "]\nCociente de MR y HRRinv ponderado 












############################# PFS y OS ######################################### 
abslogMRHRR <- abs(logMRHRR) 
mod.lm <- lm(abslogMRHRR~dades2$Type,weights=1/EE^2) 
summary(mod.lm) 
CI <- confint(mod.lm)[2,] 
est <- mod.lm[[1]]["dades2$TypePFS"] 
cat("La estimación de la diferencia del valor absoluto de log(MR·HRR) entre PFS y OS 
  es:",round(est,2),"[",round(CI[1],2),",",round(CI[2],2),"]\n") 
cat("La estimación del cociente de MR·HRR entre PFS y OS 
  es:",round(exp(est),2),"[",round(exp(CI[1]),2),",",round(exp(CI[2]),2),"]\n") 
##### IC de la diferència ponderada i corregida pel DEFF 
amplitud <- DEFF*(CI[2]-est) 
CI2 <- c() 
CI2[1] <- est-amplitud 
CI2[2] <- est+amplitud 
cat("Diferencia entre el logaritmo de MR y el logaritmo HRRinv ponderada 
  es:",round(est,3),"[",round(CI2[1],3),",",round(CI2[2],3), 
    "]\nCociente de MR y HRRinv ponderado 




########################## Abans de 2005 vs. després ########################### 
YearCat <- as.factor(ifelse(dades2$Year>2005,">2005","<=2005")) 
mod.lm <- lm(abslogMRHRR~YearCat,weights=1/EE^2) 
CI <- confint(mod.lm)[2,] 
est <- mod.lm[[1]]["YearCat>2005"] 
cat("La estimación de la diferencia del valor absoluto de log(MR·HRR) entre después y antes de 2005 
  es:",round(est,2),"[",round(CI[1],2),",",round(CI[2],2),"]\n") 
cat("La estimación del cociente de MR·HRR entre después y antes de 2005 
  es:",round(exp(est),2),"[",round(exp(CI[1]),2),",",round(exp(CI[2]),2),"]\n") 
##### IC de la diferència ponderada i corregida pel DEFF 
amplitud <- DEFF*(CI[2]-est) 
CI2 <- c() 
CI2[1] <- est-amplitud 
CI2[2] <- est+amplitud 
cat("Diferencia entre el logaritmo de MR y el logaritmo HRRinv ponderada 
  es:",round(est,3),"[",round(CI2[1],3),",",round(CI2[2],3), 
    "]\nCociente de MR y HRRinv ponderado 





# Medianes gràfiques                                                           # 
# Concordança entre la mediana real, l'observada gráficament per Lourdes  i per# 
# mi mateix                                                                    # 
################################################################################ 
 





#                                   Publication Bias                           # 
################################################################################ 
 
############################## Funnel plot alternatiu ########################## 
effect <- with(dades2,log(MedRat)-log(HRR)) 
par(mfrow=c(1,1),mar=c(6,6,3,1),las=1,cex.lab=0.8,cex.axis=0.8) 
funnelplot(effect, EE, plot.conf=FALSE,mirror=FALSE, 




############################## Meta-regresión ################################## 
# Efecto global y varianza global 
TE.fixed <- EstRatio2 
seTE.fixed <- EEglobal 
par(mfrow=c(1,1),las=1,lwd=1,cex=1.2) 
(linreg <- metabias(effect, EE,method = "linreg",plotit = TRUE, correct = FALSE)) 
 
 
### Estimación puntual y IC del sesgo 
# If method is "linreg", the test statistic is based on a weighted linear  
# regression of the treatment effect on its standard error (Egger et al., 1997).  
# The test statistic follows a t distribution with number of studies - 2 degrees 
# of freedom.  
Bias <- linreg$est[1] 
BiasSE <- linreg$est[2] 







# metabias(effect, EE,method = "mm",plotit = TRUE, correct = FALSE) 











### Mètode 1: Ajust empíric 
AjusteEmpirico(dades2,EE) 
 
### Mètode 2: Simulació 
AjusteSimula(n=50,nsim=50,replic=50) 
 
### Mètode 3: Simulació en funció de log(HRR) 
AjusteSimula2(n=50,nsim=50,replic=50) 
 





Script 2. Funcions auxiliars emprades per l'script principal. 
####################### Carregar llibreries #################################### 
library(epiR)     # Concordancia de Lin. epi.ccc 
library(irr)      # CCI (Intraclass correlation coefficient) para la concordancia (cci) 
library(nlme)     # ICC con modelos de efectos aleatorios (lme) 
library(psych)    # geometric.mean 
library(rmeta)    # (funnelplot) Funnel plot alternativo 






# Realitza la descriptiva gràfica 
# dades: les dades de les quals s'ha de fer la descriptiva 
################################################################################ 
 
GraphDescript <- function(dades){ 
   
  attach(dades) 
  DifZero <- function(x){sum(x!=0)}   # Funció auxiliar 
   
  ############################# Gràfics categòriques ########################### 
     
  ##### Descriptiva per articles 
  par(mfrow=c(2,2),las=1) 
  YearT <- apply(table(CodeArt,Year),2,DifZero) 
  barplot(YearT,main="Publication year",ylab = "Papers (no.)",las=2) 
  barplot(table(table(CodeArt)),main="Number of measures",ylab = "Papers (no.)") 
     
  ##### Descriptiva per mesures 
  barplot(table(Outcome),main="Category",ylab = "Outcomes (no.)",ylim=c(0,80)) 
  barplot(table(Type),main="Type",ylab = "Outcomes (no.)",ylim=c(0,80)) 
  detach(dades)   
 
 
  ############################# Gràfics numèriques ############################# 
    
  dadesAux <- subset(dades,dades$Num==1)  # Seleccionem un representant de cada estudi 
   
  ##### Box-plots 
  win.graph() ; par(mfrow=c(1,4),las=1) 
  boxplot(dadesAux$N,ylim=c(0,1850),ylab="Patients (no.)",main="Sample size") 
  boxplot(dades$E,ylim=c(0,1850),ylab="Patients (no.)",main="Total number of events") 
   
  #win.graph() ; par(mfrow=c(1,2),las=1) 
  boxplot(log(dades$HRR),ylim=c(-1.5,0.2),main=expression(bold(Log~bgroup("(",HRR^-1,")")))) 
  boxplot(log(dades$MedRat),ylim=c(-1.5,0.2),main=expression(bold(Log~bgroup("(",MR,")")))) 
 
  ##### Gràfics de segments 
  win.graph(300,150) 
  par(mfrow=c(1,3),las=1,cex.axis=1.1) 
   
  ### All data 
  plot(NULL,xlim=c(0,1),ylim=c(-1.5,0.1),xaxt="n",xlab="",ylab="",main="All data") 
  axis(1,at=c(0,1),label=c(expression(Log~bgroup("(",HRR^-1,")")),expression(Log~bgroup("(",MR,")")))) 
  segments(0,log(dades$HRR),1,log(dades$MedRat),col=1) 
 
  ### OS 
  selType <- which(dades$Type=="OS") 
  plot(NULL,xlim=c(0,1),ylim=c(-1.5,0.1),xaxt="n",xlab="",ylab="",main="OS") 
  axis(1,at=c(0,1),label=c(expression(Log~bgroup("(",HRR^-1,")")),expression(Log~bgroup("(",MR,")")))) 
  segments(0,log(dades$HRR[selType]),1,log(dades$MedRat[selType]),col=2) 
 
  ### PFS 
  plot(NULL,xlim=c(0,1),ylim=c(-1.5,0.1),xaxt="n",xlab="",ylab="",main="PFS") 
  axis(1,at=c(0,1),label=c(expression(Log~bgroup("(",HRR^-1,")")),expression(Log~bgroup("(",MR,")")))) 












# Realitza la descriptiva numèrica 
# dades: les dades de les quals s'ha de fer la descriptiva 
################################################################################ 
 
NumDescript <- function(dades){ 
 
  attach(dades) 
  DifZero <- function(x){sum(x!=0)}   # Funció auxiliar 
  YearT <- apply(table(CodeArt,Year),2,DifZero) 
  detach(dades) 
  dadesAux <- subset(dades,dades$Num==1)  # Seleccionem un de cada estudi 
   
  ############################# Descriptiva numèrica ########################### 
   
  ##### Proporcions dels articles 
  cat("\n---------------------- Proportions --------------------------------\n") 
  cat("Publication year\n") 
  print(round(prop.table(YearT),2)) 
  cat("\n") 
  print(round(prop.table(table(table(dades$CodeArt),dnn="Measures by paper")),2)) 
  cat("\n")   
  print(round(prop.table(table(dades$Outcome,dnn="Outcome category")),2)) 
  cat("\n")   
  print(round(prop.table(table(dades$Type,dnn="Outcome Type")),2)) 
  cat("\n")   
  print(table(dades$CodiSearch,dnn="Criterio de búsqueda por medidas")) 
  cat("Criterio de búsqueda por artículos\n") 
  print(table(dades$Num,dades$CodiSearch)[1,]) 
  cat("\n") 
 
   
  ##### Taules de contingència 
  cat("\n--------------------------- n -------------------------------------\n") 
  Papers <- subset(dades,Num=="1") 
  cat("\nYear") ;  print(table(Papers$Year)) 
  cat("\nNumber of measures") ;  print(table(tapply(dades$Num,dades$CodeArt,max))) 
  cat("\nMain outcome") ;  print(table(dades$Outcome)) 
  cat("\nOutcome type") ;  print(table(dades$Type)) 
   
  ##### Estadístics variables contínues 
  cat("\n------------------- Continue outcomes -------------------------------")  
  cat("\nSample Size\n") ; print(summary(dadesAux$N)) 
  cat("SD: ",sd(dadesAux$N),"\n") 
  cat("\nEvents\n") ; print(summary(dades$E)) 
  cat("SD: ",sd(dadesAux$E,na.rm=T),"\n") 
  cat("\nLog(HRR)\n") ; print(summary(log(dades$HRR))) 
  cat("SD: ",sd(log(dades$HRR)),"\n") 
  cat("\nLog(MR)\n") ; print(summary(log(dades$MedRat))) 










# Crea finestres per gràfics amb mateixa escala en x e y amb mfrow=c(1,2) 
# heigth: Alçada del gràfic 
################################################################################ 
 
WinSize <- function (heigth){ 
 margin <- par('mar')-0.1 
 plotSize <- heigth - sum(margin[c(1,3)]) 
 widthSize <- 2*(plotSize + sum(margin[c(2,4)])) 
 correction <- 118/125 













# Dibuixa els eixos i les etiquetes en el digrama bivariant 
# dades2: dades per fer el gràfic 
################################################################################ 
 
AxisPlot1 <- function(dades2){ 
  ##### Eixos en escala logarítmica 
  B <- exp(seq(-2,0,0.2)) 
  Bchar <- formatC(seq(-2,0,0.2)) 
  axis(1,at=B,labels=Bchar,cex=0.9) 
  axis(2,at=B,labels=Bchar,cex=0.9) 
 
  ##### Eixos en escala normal 
  A <- seq(0.2,1,0.2) 
  Achar <- formatC(A,1,format="f") 
  axis(3,at=A,labels=Achar,cex=0.9) 
  axis(4,at=A,labels=Achar,cex=0.9) 
   
  ### Etiquetes 
  mtext(expression(HRR^-1),3,line=2,at=sqrt(xymin*xymax),cex=0.9,las=0) 
  mtext("MR",4,line=2,at=sqrt(xymin*xymax),cex=0.9,las=0) 
   
  ### Ablines per veure discordances 
  abline(v=1,lty=3,col="grey80") 







# Gràfic Bland-Altman de concordança 
# x: valors de x 
# y: valors de y 
# tit: títol del gràfic 
# size: grandaria punts 
# co: color dels punts 
# ID: identificador pels punts 
# limx: vector amb els límits per l'eix de les x's  (per defecte, ho ajusta als valors) 
# limy: valor positiu limit per l'eix de les y's (per defecte, ajusta als valors conservant simetria 
vertical) 
################################################################################ 
BlandAltman <- function(x,y,tit="Bland-Altman",size,co,ID=NULL,limx=NULL,limy=NULL){ 
 
 Bmean <- (x+y)/2 
 Bdif <- y-x 
 
  ##### Límit de l'eix de les y's 
 if (is.null(limy))  ymax <- max(abs(Bdif),na.rm=T) 
 if (!is.null(limy)) ymax <- limy 
 
  ##### Gràfic 
 plot(Bmean ,Bdif ,ylim=log(c(1/ymax,ymax)),xlim=limx,main=tit,cex=size,col=co, 
        xlab=expression(log~bgroup("(",sqrt(MR%.%HRR^-1),")")), 
      ylab=expression(log~bgroup("(",frac(MR,HRR^-1),")"))) 
  
  ##### Etiquetes 
  mtext("Greater MR",2,line= 0.5,at=log(ymax),adj=1,cex=0.9) 
 mtext("Greater HRR",2,line= 0.5,at=-log(ymax),adj=1,cex=0.9) 
 
  ##### Identificador 
 if(!is.null(ID)) text(Bmean,Bdif,ID,pos=4,cex=0.6) 
 


















# Dibuixa els eixos i les etiquetes en el gràfic de Bland Altman 
# x: 1a variable 
# y: 2a variable 
# xtick: vector con número de puntos  
# ytick: vector con número de puntos  
 
AxisBlandAltman <- function(x,y,xtick=NULL,ytick=NULL,EE=NULL,Type=NULL,addlines=FALSE){ 
  ### Punts on va l'eix Y 
  Puntsya <- log(c(1/(5:3),1:4/2:5,1,5:3/4:2,2:5)) 
  PuntsCharya <- c(paste("1/",5:3,sep=""),paste(1:4,"/",2:5,sep=""),1,c(paste(5:3,"/",4:2,sep=""),2:5)) 
  if(is.null(ytick)){ 
    Puntsy <- Puntsya[c(2:6,8,10:14)] 
    PuntsChary <- PuntsCharya[c(2:6,8,10:14)] 
  }        
  if(!is.null(ytick)){ 
    Puntsy <- Puntsya[ytick] 
    PuntsChary <- PuntsCharya[ytick] 
  } 
  ### Punts on va l'eix X   
  Puntsxa <- log(c(seq(0.2,1,0.2),seq(1.5,5,0.5))) 
  PuntsCharxa <- formatC(c(seq(0.2,1,0.2),seq(1.5,5,0.5)),1,format="f") 
 
  if(is.null(xtick)){ 
    Puntsx <- Puntsxa 
    PuntsCharx <- PuntsCharxa 
  }        
  if(!is.null(xtick)){   
    Puntsx <- Puntsxa[xtick] 
    PuntsCharx <- PuntsCharxa[xtick] 
  } 
  ### Dibuixar eixos 
  xymin <- min(log(sqrt(x*y))) ; xymax <- max(log(sqrt(x*y))) 
  axis(3, at = Puntsx , labels = PuntsCharx,cex=0.9) 
  axis(4, at = Puntsy, labels = PuntsChary,cex=0.9) 
   
  ### Ablines 
  abline(h=Puntsy,lty=3,col="lightgrey") 
  abline(h=0,lty=2) 
   
  ### Label 
  mtext(expression(sqrt(MR%.%HRR^-1)),3,line=2,at=mean(c(xymin,xymax)),cex=0.9) 
  mtext(expression(frac(MR,HRR^-1)),4,line=3,at=0,cex=0.9,las=0) 
   
  ### Confidence intervals 
  MR <- x 
  HRR <- y 
  M <- ifelse(is.null(EE),mean(log(MR/HRR)),weighted.mean(log(MR/HRR),1/EE)) 
  SD <- sd(log(MR/HRR),na.rm=TRUE) 
  cat("SD (data):",SD,"\n") 
  abline(h=M,col=4,lwd=1) 
  abline(h=M+c(2*SD,-2*SD),lty=4,col=4) 
 
  ### Lectura de les desviacions 
  if(addlines){ 
    setwd('E:\\TFM\\RecercaHRRvsMediana\\Concordancias simuladas') 
    ExpAll <- mean(read.table('ExpPartialdataAllResponse.txt',header=T)[,2]) 
    ExpOS <- mean(read.table('ExpPartialdataOS.txt',header=T)[,2]) 
    ExpPFS <- mean(read.table('ExpPartialdataPFS.txt',header=T)[,2]) 
     
    WeibAll <- mean(read.table('WeibPartialdataAllResponse.txt',header=T)[,2]) 
    WeibOS <- mean(read.table('WeibPartialdataOS.txt',header=T)[,2]) 
    WeibPFS <- mean(read.table('WeibPartialdataPFS.txt',header=T)[,2]) 
     
    # Datos sacados de las simulaciones SimulaBlandAltman.r 
    SDExp <- ifelse((is.null(Type) | Type=="Global"),ExpAll,ifelse(Type=="OS",ExpOS,ExpPFS))         
    SDWei <- ifelse((is.null(Type) | Type=="Global"),WeibAll,ifelse(Type=="OS",WeibOS,WeibPFS)) 
     
    abline(h=c(-2*SDExp,2*SDExp),lty=4,col="orange")   
    abline(h=c(-2*SDWei,2*SDWei),lty=4,col=6) 
    legend('topright',c("Perfect concordance","Weighted Mean (Data)", 
  "Mean +/- 2SD (Data)","Mean +/- 2SD (Exp)","Mean +/- 2SD (Weib)"), 
             lty=c(2,1,4,4,4),col=c(1,4,4,"orange",6),lwd=1,cex=0.7,bg="white") 
  } 
  if(!addlines){ 
    legend('topright',c("Perfect concordance","Weighted Mean (Data)","Mean +/- 2SD (Data)"), 
            lty=c(2,1,4),col=c(1,4,4),lwd=1,cex=0.7,bg="white")      
  } 
}   
 89
################################################################################ 
# Dibuixa els IC del 95% teòrics i la mitja geomètrica i la mediana en B-A 
################################################################################  
FunnelLines <- function(dades2){ 
  gm <- geometric.mean(dades2$MedRat/dades2$HRR) 
  med <- median(dades2$MedRat/dades2$HRR) 
  abline(v=gm, lwd=2,col=4) 
  abline(v=med, lwd=2, col=2,lty=3) 
  legend('topleft',c("Concordance","Geometric mean","Median","Mean Significance (95%)","Individual 
significance (90%)"),lty=c(2,1,3,4,4),col=c(1,4,2,3,"darkgreen"),lwd=c(1,2,2,1,1),cex=0.8) 
   
  ### Línies de significació 
  yizq <- seq(0,20,0.01) 
  xizq1 <- log(gm)+1.96*1/yizq 
  xizq2 <- log(gm)-1.96*1/yizq 
  lines(exp(xizq1),yizq ,lty=4,col=3) 
  lines(exp(xizq2),yizq ,lty=4,col=3) 
  points(dades2$MedRat/dades2$HRR,1/EE,cex=0.8) 
   
  ### Etiquetes 
  mtext("|log(MR)| > |log(HRR)|",side=1,line=2.4,at=1/ma,adj=0.5,cex=0.8,font=2) 
  mtext("|log(MR)| < |log(HRR)|",side=1,line=2.4,at=ma,adj=0.5,cex=0.8,font=2) 
  mtext("HRR<1",side=3,line=0.5,at=1,cex=0.9,font=2) 




# IC empírico del 90% por bootstrap 
# 1. Se cogen los m (20) puntos con menor EE (es decir con mayor 1/EE) 
# 2. Se seleccionan r (20) de ellos con reposición 
# 3. Se mira donde cae el cociente MR/HRR segundo (es decir el que deja un 5% de los puntos por 
#    la izquierda) y el MR/HRR (r-1) (es decir el que deja un 5% de los puntos por la derecha) 
# 4. El promedio de nboots (100) de los puntos segundos será el LI del IC a la altura promedio 
#    de los 1/E de estos 20 puntos. Para el LS del IC se hará con el punto 19 
# 5. Se repite el proceso para los puntos del 2 al 21 con menor EE 
################################################################################ 
FunnelEmpiric <- function(dades2,EE){ 
  m <- 10 
  r <- 20 
  nboots <- 100 
  sortEE <- sort(EE) 
  ordenEE <- order(EE) 
  MR <- dades2$MedRat 
  HRR <- dades2$HRR 
  MRHRR <- MR/HRR 
  MRHRRorder <- MRHRR[ordenEE] 
  L <- length(EE) 
   
  EEinv <- c() 
  LI <- c() 
  LS <- c() 
   
  for (i in 1:(L-m+1)){ 
    primero <- i 
    ultimo <- (i+m-1) 
    EEinv[i] <- mean(1/sortEE[primero:ultimo]) 
    mpuntos <- MRHRRorder[primero:ultimo] 
    linf <- c() 
    lsup <- c() 
    for (j in 1:nboots){ 
      muestra <- sort(sample(mpuntos,r,replace=TRUE)) 
      linf[j] <- muestra[2] 
      lsup[j] <- muestra[r-1] 
    } 
    LI[i] <- geometric.mean(linf) 
    LS[i] <- geometric.mean(lsup) 
  } 
### Lineas 
  lowessLI <- lowess(EEinv,LI) 
  yLI <- lowessLI$x 
  xLI <- lowessLI$y 
   
  lowessLS <- lowess(EEinv,LS) 
  yLS <- lowessLS$x 
  xLS <- lowessLS$y 
   
  lines(xLS,yLS,lty=4,col="darkgreen") 




################################################################################   
# Coeficient de Lin ponderat per size 
# Retorna un vector amb el Lin sense ponderar calculat a mà (Article de Lin) i 




LinWeigth <- function(dades,size){ 
  WT <- size/sum(size) 
  x <- log(dades$MedRat) 
  y <- log(dades$HRR) 
   
  COV.WT <- cov.wt(cbind(x,y),wt = WT) 
  mux.WT <- weighted.mean(x, WT) 
  muy.WT <- weighted.mean(y, WT) 
   
  co <- COV.WT$cov[2,1] 
  varx <- COV.WT$cov[1,1] 
  vary <- COV.WT$cov[2,2] 
  cat('Para los logaritmos:') 
  cat ('mu(MR):',mux.WT,'var(MR):',varx,'mu(HRR):',muy.WT,'var(HRR):',vary,'Covar(M,HRR):',co,'\n') 
 
  Lin <- (2*cov(x,y))/(var(x)+var(y)+(mean(x)-mean(y))^2)    
  LinWeight <- (2*co)/(varx+vary+(mux.WT-muy.WT)^2) 
   
  ############ Interval de confiança (article biometrics Lin original p.258-9) ###### 
  u <- (mux.WT-muy.WT)/sqrt(varx*vary) 
  rho <- co/sqrt(varx*vary) 
  rhoc <- LinWeight 
  n <- length(x) 
  #A <- ((1-rho^2)*rhoc^2)/((1-rhoc^2)*rho^2) 
  #B <- (4*rhoc^3*(1-rhoc^2)*u^2)/((1-rhoc^2)^2*rho)   
  #C <- (2*(rhoc*u)^4)/((1-rhoc^2)^2*rho^2)   
 
  A <- ((1-rho^2)*(1-rhoc^2)*rhoc^2)/(rho^2) 
  B <- (4*rhoc^3*(1-rhoc)*u^2)/rho   
  C <- (2*(rhoc*u)^4)/(rho^2)   
 
  VarLinWeight <- (A+B-C)/(n-2) 
  z <- qnorm(0.975) 
  LI <- LinWeight-z*sqrt(VarLinWeight)  
  LS <- LinWeight+z*sqrt(VarLinWeight)   
  cat("Intervalo de confianza: ",round(LI,2)," to ",round(LS,2)," \n") 
 







# Printa la interpretació del coeficient de Lin 
################################################################################ 
 
LinInterpretation <- function(){ 
  cat("Valoració de la concordança:\n") 
  cat("0.0-0.1: Independence\n") 
  cat("0.1-0.3: Bad\n") 
  cat("0.3-0.5: Poor\n") 
  cat("0.7-0.9: Good\n") 
  cat("0.9–1.0: Almost perfect\n\n") 
  cat("Referencia principal: Mail de Josep LLuís carrasco \n") 
  cat("Referencia: Robust estimators of the concordance correlation coefficient.\n") 























MedianConcordance <- function(medianas){ 
  ### Plot 
  par(mfrow=c(1,2),cex=1.2,mar=c(4,4,1,1)) 
  plot(medianas$Real,medianas$Jordi,xlab="Mediana Real",ylab="Mediana Estimada",las=1) 
  points(medianas$Real,medianas$Lourdes,col=2) 
  legend("topleft",c("Jordi","Lourdes"),col=1:2,pch=1) 
  abline(0,1,lty=2) 
   
 
  ### Bland-Altman Normal 
  xJ <- (medianas$Real+medianas$Jordi)/2 
  yJ <- (medianas$Real-medianas$Jordi) 
  xL <- (medianas$Real+medianas$Lourdes)/2 
  yL <- (medianas$Real-medianas$Lourdes) 
  xmin <- min(c(xJ,xL)) 
  xmax <- max(c(xJ,xL)) 
  ymax <- max(abs(c(yJ,yL))) 
  plot(xJ,yJ,xlab="Average",ylab="Difference",xlim=c(xmin,xmax),ylim=c(-ymax,ymax)) 
  points(xL,yL,col=2) 
  abline(h=0,lty=2) 
  legend("topleft",c("Jordi","Lourdes"),col=1:2,pch=1) 
   
  ### Plot 
  win.graph() 
  par(mfrow=c(1,2),cex=1.2,mar=c(4,4,1,1)) 
  plot(medianas$Real,medianas$Jordi,xlab="Mediana Real",ylab="Mediana Estimada",las=1) 
  points(medianas$Real,medianas$Lourdes,col=2) 
  legend("topleft",c("Jordi","Lourdes"),col=1:2,pch=1) 
  abline(0,1,lty=2) 
   
  ### Bland-Altman logaritmic 
  xJ <- sqrt(medianas$Real*medianas$Jordi) 
  yJ <- (medianas$Real/medianas$Jordi) 
  xL <- sqrt(medianas$Real*medianas$Lourdes) 
  yL <- (medianas$Real/medianas$Lourdes) 
  xmin <- min(c(xJ,xL)) 
  xmax <- max(c(xJ,xL)) 
  ymax <- max(abs(c(yJ,yL))) 
  plot(xJ,yJ,xlab="Geometric Average",ylab="Division", 
 xlim=c(xmin,xmax), ylim=c(1/ymax,ymax),log=c("x","y")) 
  points(xL,yL,col=2) 
  abline(h=1,lty=2) 
  legend("topright",c("Jordi","Lourdes"),col=1:2,pch=1) 
   
  ### icc 
  M <- medianas[,3:5] 
  concRJ <- epi.ccc(medianas$Real,medianas$Jordi)$rho.c 
  concRL <- epi.ccc(medianas$Real,medianas$Lourdes)$rho.c 
  concLJ <- epi.ccc(medianas$Lourdes,medianas$Jordi)$rho.c 
  cat("Concordancia entre la mediana Real y la mediana evaluada por Jordi:\n") 
  print(concRJ) 
  cat("Concordancia entre la mediana Real y la mediana evaluada por Lourdes:\n") 
  print(concRL) 
  cat("Concordancia entre la mediana evaluada por Lourdes y la evaluada por Jordi:\n")     






















# Converteix les dades en una llista d'articles amb 2 mesures de OS i PFS en 




DataForICC <- function(dades2){ 
 
  ### Seleccionar los estudios con al menos una medida de PFS y una de OS 
  Aux <- split(dades2,dades2$CodeArt)         # Lista con cada artículo un ítem 
  nArt <- length(Aux)                         # Número de artículos 
  elim <- c()                                 #  
  for (i in 1:nArt){ 
    if(length(unique(Aux[[i]]$Type))!=2) elim <- c(elim,i) 
  } 
  Aux2 <- Aux[-elim] 
   
  ### Seleccionar el primer PFS y el primer OS de cada estudio 
  nArt2 <- length(Aux2) 
  for (i in 1:nArt2){ 
    selOS <- min(which(Aux2[[i]]$Type=="OS")) 
    selPFS <- min(which(Aux2[[i]]$Type=="PFS")) 
    Aux2[[i]] <- Aux2[[i]][c(selOS,selPFS),] 
  } 






# Converteix lla llista anterior en una matriu de dues columnes amb les  




DataForICC2 <- function (dades3){ 
  Npapers <- length(dades3) 
  DiscrepanciesMatrix <- matrix(NA,ncol=2,nrow=0)             
  for (i in 1:Npapers){ 
    Dis <- with(dades3[[i]],log(MedRat)-log(HRR)) 
    DiscrepanciesMatrix <- rbind(DiscrepanciesMatrix,Dis) 
  } 
  rownames(DiscrepanciesMatrix) <- names(Aux2) 
  colnames(DiscrepanciesMatrix) <- c("OS","PFS") 







# Converteix lla llista anterior en una matriu de dues columnes amb les  




ICCEfectesAleatoris <- function(MR_HRRMatrix){ 
  logMR_logHRR <- c(as.numeric(MR_HRRMatrix[,1]),as.numeric(MR_HRRMatrix[,2])) 
  Paper <- as.factor(c(1:Npapers,1:Npapers)) 
  mod.lme <- lme(logMR_logHRR ~ 1,random = ~ 1|Paper) 
  StdDevR <- mod.lme$sigma 
  StdDevI <- sqrt(mod.lme$apVar[1,1]) 
  ICC <- StdDevI^2/(StdDevI^2+StdDevR^2) 





Script 3. Funcions auxiliars usades en l'script principal per estimar la variabilitat del log(MR/HRR-1) 
################################################################################ 
#                                                                              # 
# Estimació de la Var(log(MR/HRR)) en funció de la Var(log(1/HRR))             # 




# Mètode 2 
# 1. Dividir els punts en decils segons X=1/Var(Log(HRR)) 
# 2. Calcular la Y=Var(Log(MR/HRR)) dins de cada decil de forma empírica 
# 3. Fer regressió Y vs X 
################################################################################ 
 
AjusteEmpirico <- function(dades2,EE){ 
  # 1. Dividir en deciles (Se debe haber ejecutado antes el script principal) 
  Xaux <- (EE)^2   
  brk <- quantile(Xaux, probs = seq(0, 1, 0.1))    # Tallo els EE en decils 
  X <- (brk[1:10]+brk[2:11])/2                # Agafo els representants de classe  
  brk[1] <- brk[1]-0.0004                     # Resto un epsilon al primer 
 
  DecilFactor <- cut(Xaux,brk) 
   
  # 2. Calcular Var(Log(MR/HRR)) para cada decil 
  Yaux <- with(dades2,log(MedRat/HRR)) 
  Y <- tapply(Yaux,DecilFactor,var) 
   
  # 3. Regressió 
  mod.lm <- lm(Y~X) 
  par(mfrow=c(1,1),mar=c(5,5,5,1),las=1) 
  plot(X,Y,xlab=expression(V~bgroup("(",log(HRR),")")), 
 ylab=expression(V~bgroup("(",log~bgroup("(",frac(MR,HRR),")"),")")), 
      cex.lab=0.65,xlim=c(0,0.14),ylim=c(0,0.14)) 
  coeff <- coef(mod.lm) 













































# Mètode 3 
# 1. Simular temps de vida exponencials per dos tractaments 
# 2. Confrontar la variabilitat del logaritme de MR/HRR i del logaritme de HRR amb 
#    diferents lambdas. La variabilitat del logaritme de quocients és la suma de variancies 
#    dels seus logaritmes 
# 3. Fer regressió 
# n: Grandària mostral; 
# nsim: Número de simulacions;    
# replic:repliques per estimar la variància del logaritme del rati de medianes 
################################################################################ 
 
AjusteSimula <- function(n,nsim,replic){ 
  set.seed(12345) 
  V.LOG.HRRinv <- c()               ; log.hrrinv <- c() 
  V.LOG.MR.HRRinv <- c()            ; log.mr.hrrinv <- c() 
  V.LOG.MR.HRRinv.MINUS.2COV <- c() ; log.mr <- c() 
 
  for (i in 1:nsim){ 
    lambda1 <- runif(1,1/4,1) ; lambda2 <- runif(1,1/4,1)       # Paràmetres de l'exponencial 
 
    for (j in 1:replic){ 
      A <- rexp(n,lambda1) ;    B <- rexp(n,lambda2)            # Temps de vida 
      Resposta <- c(A,B) 
      Treatment <- as.factor(c(rep(0,n),rep(1,n))) 
      status <- rep(1,2*n) 
      simSurv <- Surv(Resposta,status) 
      simSurvfit <- survfit(simSurv~Treatment) 
      cox.mod <- coxph(simSurv~Treatment) 
      Tab <- summary(simSurvfit)$table 
      MR <- Tab["Treatment=1","median"]/Tab["Treatment=0","median"] 
 
      log.hrrinv[j] <- (-cox.mod[[1]])                     # Log(HRR) 
      log.mr[j] <- log(MR)                                 # Log(MR) 
      log.mr.hrrinv[j] <- log.mr[j] - log.hrrinv[j]        # Log(MR)-Log(HRR) 
    } 
 
    # Variància del logaritme del HRR 
    V.LOG.HRRinv[i] <- var(log.hrrinv) 
 
    # V(log(HRR))- 2*Cov(log(HRR),log(MR)) 
    V.LOG.MR.HRRinv.MINUS.2COV[i] <- var(log.hrrinv) - 2*cov(log.mr,log.hrrinv) 
    V.LOG.MR.HRRinv[i] <- var(log.mr.hrrinv) 
  } 
   
  par(mfrow=c(1,2),las=1,mar=c(5,5,5,1)) 
   
  ### Y=Var(log(MR/HRR)) vs X=Var(log(HRR)) 
  plot(V.LOG.HRRinv,V.LOG.MR.HRRinv,xlim=c(0,0.1),ylim=c(0,0.1), 
        xlab=expression(V~bgroup("(",log(HRR),")")), 
 ylab=expression(V~bgroup("(",log~bgroup("(",frac(MR,HRR),")"),")")),cex.lab=0.65) 
  mod.lm <- lm(V.LOG.MR.HRRinv~V.LOG.HRRinv) 
  coeff <- coef(mod.lm) 
  abline(coeff[1],coeff[2]) 
  abline(0,1,col=2,lty=2) 
 
   
  ### Y =Var(log(MR/HRR)) vs X2 = Var(log(HRR))-2*Cov(log(MR),log(HRR)) 
  plot(V.LOG.MR.HRRinv.MINUS.2COV,V.LOG.MR.HRRinv,xlim=c(-0.1,0),ylim=c(0,0.1), 
        xlab=expression(V~bgroup("(",log(HRR),")")-2*Cov~bgroup("(",list(log~bgroup("(",MR,")"), 
   log~bgroup("(",HRR,")")),")")), 
        ylab=expression(V~bgroup("(",log~bgroup("(",frac(MR,HRR),")"),")")),cex.lab=0.65) 
 
  mod.lm <- lm(V.LOG.MR.HRRinv~V.LOG.MR.HRRinv.MINUS.2COV) 
  coeff <- coef(mod.lm) 
  abline(coeff[1],coeff[2],lty=2) 
  abline(0,1,col=2) 
   













# Mètode 4.1 
# 1. Simular temps de vida exponencials per dos tractaments 
# 2. Calcular la variança del logaritme del HRR, del MR y de MR/HRR, així  
# com la seva correlació amb el logaritme del HRR i amb la grandaria mostral. 
# 3. Fer regressió 
# n: Grandaria mostral;    nsim: Número de simulacions;    
# replic:rèpliques per estimar la variància del logaritme del rati de medianes 
################################################################################ 
 
AjusteSimula2 <- function(n,nsim,replic){ 
 
   
  ### 1. Avaluar l'efecte de l'efecte en les variàncies 
   
  set.seed(12345) 
  varLogMR <- c() ;  varLogHRR <- c() 
  varLogMRHRR <- c();  covarLogMRHRR <- c() 
  corLogMRHRR <- c();  corLogMRHRRinv <- c() 
  logMR <- c();  logHRR <- c();  logMRHRR <- c();  HRR <- c() 
   
  for (i in 1:nsim){ 
    lambda1 <- runif(1,1/3,1)         # Taxes entre 1/3 y 1 
    lambda2 <- runif(1,1/3,1)         # Taxes entre 1/3 y 1 
    for (j in 1:replic){ 
      A <- rexp(n,lambda1) 
      B <- rexp(n,lambda2) 
      Resposta <- c(A,B) 
      Treatment <- c(rep(0,n),rep(1,n)) 
      status <- rep(1,2*n) 
     simSurv <- Surv(Resposta,status) 
     simSurvfit <- survfit(simSurv~Treatment) 
     SS <- summary(simSurvfit) 
     cox.mod <- coxph(simSurv~Treatment) 
     Tab <- SS$table 
     M1 <- Tab["Treatment=1","median"]          # Mediana 1 
     M0 <- Tab["Treatment=0","median"] 
     logMR[j] <- log(M1/M0) 
     logHRR[j] <- cox.mod[[1]] 
     logMRHRR[j] <- logMR[j]-logHRR[j] 
    } 
 
    varLogMR[i] <- var(logMR) 
    varLogHRR[i] <- var(logHRR) 
    varLogMRHRR[i] <- var(logMRHRR) 
    corLogMRHRR[i] <- cor(logMR,logHRR) 
    corLogMRHRRinv[i] <- cor(logMR,1/logHRR) 
    covarLogMRHRR[i] <- cov(logMR,logHRR) 
    HRR[i] <- lambda1/lambda2 
  } 
   
  par(mfrow=c(2,2),las=1) 
  plot(log(HRR),varLogMR,pch=19,xlab="log(HRR)",ylab="var(log(MR))") 
  abline(v=0,lty=2) 
  plot(log(HRR),varLogHRR,pch=19,xlab="log(HRR)",ylab="var(log(HRR))") 
  abline(v=0,lty=2) 
  plot(log(HRR),varLogMRHRR,pch=19,xlab="log(HRR)",ylab="var(log(MR/HRR))") 
  abline(v=0,lty=2) 
  plot(log(HRR),corLogMRHRR,pch=19,xlab="log(HRR)",ylab="cor(log(MR),log(1/HRR))") 
  abline(v=0,lty=2) 
   
 
  ### Descriptiva 
  print(summary(varLogMR)) 
  print(summary(varLogHRR)) 
  print(summary(varLogMRHRR)) 















# Mètode 4.2 
# 1. Simular temps de vida exponencials per dos tractaments 
# 2. Calcular la variança del logaritme del HRR, del MR y de MR/HRR, així  
# com la seva correlació amb el logaritme del HRR i amb la grandaria mostral. 
# 3. Fer regressió 
# ene: Grandària mostral;replic:repliques para estimar la var. del logaritme del rati de medianes 
################################################################################ 
AjusteSimula3 <- function(ene,replic){ 
  varLogMR <- c() ;  varLogHRR <- c() 
  varLogMRHRR <- c();  covarLogMRHRR <- c() 
  corLogMRHRR <- c();  corLogMRHRRinv <- c() 
  logMR <- c();  logHRR <- c();  logMRHRR <- c();  HRR <- c()   
   
  ### 2. Avaluar l'efecte de la grandaria en les variàncies 
  nsim <- length(ene)         
   
  set.seed(12345) 
  varLogMR <- c() 
  varLogHRR <- c() 
  varLogMRHRR <- c() 
  covarLogMRHRR <- c() 
  corLogMRHRR <- c() 
  HRR <- c() 
 
  for (i in 1:nsim){ 
    lambda1 <- 0.8 
    lambda2 <- 1 
    n <- ene[i] 
    for (j in 1:replic){ 
      A <- rexp(n,lambda1) 
      B <- rexp(n,lambda2) 
      Resposta <- c(A,B) 
      Treatment <- c(rep(0,n),rep(1,n)) 
      status <- rep(1,2*n) 
 
     simSurv <- Surv(Resposta,status) 
     simSurvfit <- survfit(simSurv~Treatment) 
     cox.mod <- coxph(simSurv~Treatment) 
     Tab <- summary(simSurvfit)$table 
     M1 <- Tab["Treatment=1","median"]           
     M0 <- Tab["Treatment=0","median"] 
 
     logMR[j] <- log(M1/M0) 
     logHRR[j] <- cox.mod[[1]] 
     logMRHRR[j] <- logMR[j]-logHRR[j] 
    } 
 
    varLogMR[i] <- var(logMR) 
    varLogHRR[i] <- var(logHRR) 
    varLogMRHRR[i] <- var(logMRHRR) 
    covarLogMRHRR[i] <- cov(logMR,logHRR) 
    corLogMRHRR[i] <- cor(logMR,logHRR) 
    HRR[i] <- lambda1/lambda2 
  } 
 
  par(mfrow=c(2,2),las=1) 
  plot(ene,1/varLogMR,pch=19,xlab="n",ylab="1/var(log(MR))") 
  abline(v=0,lty=2) 
  plot(ene,1/varLogHRR,pch=19,xlab="n",ylab="1/var(log(HRR))") 
  abline(v=0,lty=2) 
  plot(ene,1/varLogMRHRR,pch=19,xlab="n",ylab="1/var(log(MR/HRR))") 
  abline(v=0,lty=2) 
  plot(ene,corLogMRHRR,pch=19,xlab="n",ylab="cor(log(MR),log(HRR))") 
  abline(v=0,lty=2) 
   
  ### Descriptiva 
  print(summary(varLogMR)) 
  print(summary(varLogHRR)) 
  print(summary(varLogMRHRR)) 






Script 4. Script per a la realització de la Figure 1. 
################################################################################ 
# Script que demostra que la distribució Gompertz no té HRR^(-1)=MR malgrat tenir 









rho11 <- c(0.5,1,2) 
rho10 <- seq(0.01,2,0.01) 
rho2 <- c(0.5,1,2,10) 
 
n1 <- length(rho10) 
n2 <- length(rho11) 
nrho2 <- length(rho2) 
 
##### Objectes per emmagatzemar resultats 
MR <- c() ; HRR <- c() ; AR <- c() 
 
MR1 <- matrix(0, nrow=n1, ncol=nrho2)      # Mediana 1 Real 
MT1 <- matrix(0, nrow=n1, ncol=nrho2)      # Mediana 1 teórica 
colnames(MR1) <- as.character(rho2) ; colnames(MT1) <- as.character(rho2) 
rownames(MR1) <- as.character(rho10) ; rownames(MT1) <- as.character(rho10) 
MR2 <- matrix(0, nrow=n2, ncol=nrho2)      # Mediana 2 Real 
MT2 <- matrix(0, nrow=n2, ncol=nrho2)      # Mediana 2 teórica 
colnames(MR2) <- as.character(rho2) ; colnames(MT2) <- as.character(rho2) 
rownames(MR2) <- as.character(rho11) ; rownames(MT2) <- as.character(rho11) 
 
##### Inicialitzar gràfic 
layout(matrix(c(1,2,3,4,5,5), 3, 2, byrow = TRUE),heights = c(1,1,0.2)) 
par(las=1,lwd=2,mar=c(5,4,5,1),xpd=F,cex.lab=1.2,cex.axis=1.2) 
 
for (k in nrho2:1){ 
   
  scale1 <- rho2[k]            # Paràmetres d'escala (idèntics) 
  scale2 <- rho2[k] 
   
  for (j in 1:n2){ 
   shape2 <- rho11[j]        # Paràmetre de forma (tractats) 
   for (i in 1:n1){ 
   
     shape1 <- rho10[i]    # Paràmetre de forma (controls) 
       
         ### Generació dels temps (Atenció: parametrització Gompertz en R) 
         time1 <- rgompertz(10000,shape1,scale1) 
         time2 <- rgompertz(10000,shape2,scale2)       
       
         ##################### Medianes #################################### 
         med1 <- median(time1) 
         med2 <- median(time2) 
       
         ### Emmagatzemar medianes reals 
         MR1[i,k] <- med1 
         MR2[j,k] <- med2 
       
         ### Càlcul medianes teòriques 
         A <- exp(-shape1*scale1*exp(-1)) 
         B <- 1/(2*exp(1)) 
         C <- (-1/(scale1*shape1)*log(A-B)) 
         MT1[i,k] <- (1+log(C))*scale1 
       
         A <- exp(-shape2*scale2*exp(-1)) 
         C <- (-1/(scale2*shape2)*log(A-B)) 
         MT2[j,k] <- (1+log(C))*scale2 
 
         ### Mitjanes 
         mean1 <- mean(time1) 
         mean2 <- mean(time2) 
       
         HRR[i] <- shape2/shape1   # Hazard Ratio  
         MR[i] <- med2/med1   # Median Ratio 
         AR[i] <- mean2/mean1   # Rati de mitjanes 
   } 
 98
   ##################### Gràfic ####################################  
   if(j==1){ 
    plot(lowess(1/HRR,MR),xlim=c(0.1,1),ylim=c(0.1,1),asp=I,type="l",col=j, 
             log="xy",xlab=expression(HRR^-1),ylab="MR or ER") 
     
    ### En el títol s'ha d'invertir rho2 perqué la parametrització és diferent        
    title(main=bquote(bold(paste(rho[2],"=",.(1/rho2[k])))),cex.main=1.5) 
    lines(lowess(1/HRR,AR),lty=2,col=j)   
    abline(0,1,lty=3,col="grey80") 
   } 
   if(j!=1){ 
    lines(lowess(1/HRR,MR),col=j) 
    lines(lowess(1/HRR,AR),lty=2,col=j)     
   } 
  } 
} 




                expression(bold(rho[11]==1)), 
                expression(bold(rho[11]==2))), 
                horiz=T, xjust=0.5, col=c(1,1,1,2,3), lwd=c(2,2,rep(NA,3)), 
                lty=c(2,1,rep(NA,3)), pch=c(NA,NA,rep(15,3)), cex=1.5) 
segments(0.42,0.4,0.42,0.9,lwd=2) 
 
################ Mediana teòrica versus real ########################## 
par(mfrow=c(2,2),mar=rep(5,4)) 
for (i in 4:1){ 
  minxy <- min(c(MR1[,i],MT1[,i]),na.rm=T) 
  maxxy <- max(c(MR1[,i],MT1[,i]),na.rm=T) 
  plot(MR1[,i],MT1[,i],type="l",xlim=c(minxy,maxxy),ylim=c(minxy,maxxy),xlab="Real median", 
  ylab="Theoretical Median", main=bquote(paste(bold(rho[2]==""),.(1/rho2[i])))) 
  abline(0,1,lty=2,lwd=1) 








x0 <- c(0,1,2,3,4); y0 <- c(1,0.5,0.1,0.05,0) 
x1 <- c(0,1,2,3,4); y1 <- c(1,0.615,0.1,0.08,0.04) 
 
##### Paràmetres 
n <- length(x0) 
par(mfrow=c(1,1)) 
sp0 <- spline(x0,y0,method="natural") 










arrows(1.12,0.58,1,0.555,length = 0.1) 
 
HRR <- 0.7 
##### Punts Grup Control 
x0 <- c(0,1,2,3,4) 
y0 <- c(1,0.5,0.1,0.05,0) 
##### Punts Grup Tractat 
x1 <- c(x0,1.27) 
y1 <- c(y0^HRR,0.5) 
 
# Paràmetros 
n <- length(x0) 
 
par(mfrow=c(1,2),las=1) 
##### 1r gràfic 
##### Corva grup control 




##### Corva grup Tractat 
sp1 <- spline(x1,y1,method="natural") 
lines(sp1$x,sp1$y,col="grey90",lwd=1) 
 
##### Eixos i ablines 












##### 2on gràfic 
plot(sp0$x,sp0$y,type='l',xlim=c(0,2.2),ylim=c(0,1),xlab="Time t",ylab="S(t)",col="grey90", 
 lwd=1,yaxp=c(0,1,10), main="",xaxt="n",yaxt="n") 
lines(sp1$x,sp1$y,col=4,lwd=2) 














Script 6. Script per a la realització de la Figure 4, Figure 5 i Figure 6 





######################## Paràmetres ########################################### 
n <- 50                     # Grandaria mostral 
nsim <- 100                 # Nombre de simulacions 
prop0 <- 0.1                # Proporció censures controls 
prop1 <- seq(0,0.4,0.02)    # Proporció censures tractats 
nprop1 <- length(prop1)     # Número de proporcions 
lambda0 <- 1                # Paràmetre exponencial tractats 
lambda1 <- 0.8              # Paràmetre exponencial controls 
 
###### Valors teòrics en la mediana de referencia teòrica 
Mediana0 <- log(2)/lambda0  # Mediana teòrica 
 
S0 <- 0.5                   # Supervivència controls 
S1 <- 0.5^lambda1           # Supervivència tractats 
 
RR_Teo <- (1-S1)/(1-S0) 
OR_Teo <- ((1-S1)/S1)/((1-S0)/S0) 
RD_Teo <- S1 - S0  
 
###### Objectes per emmagatzemar resultats 
### Matriu per emmagatzemar OR, RR i RD 
M <- matrix(NA, nrow=9, ncol=nprop1) 
rownames(M) <- c("RR_Real","OR_Real","RD_Real","RR_Cens","OR_Cens","RD_Cens", 
  "RR_HRR","OR_HRR","RD_HRR") 
colnames(M) <- prop1 
 
### Matriu per emmagatzemar supervivències 
M2 <- matrix(NA, nrow=6, ncol=nprop1) 
rownames(M2) <- c("SKM","LI_SKM","LS_SKM","SHRR","LI_SHRR","LS_SHRR") 
colnames(M2) <- prop1 
 
RR_Real <- c() ; OR_Real <- c() ; RD_Real <- c() 
RR_Cens <- c() ; OR_Cens <- c() ; RD_Cens <- c()  
RR_HRR <- c() ; OR_HRR <- c() ; RD_HRR <- c() 
 
SKM <- c() ; LISKM <- c() ;LSSKM <- c() 
SHRR <- c() ; LISHRR <- c() ; LSSHRR <- c() 
 
###### Simulació 
for (i in 1:nprop1){ 
 for (j in 1:nsim){ 
   time1 <- rexp(n,lambda1) 
   time0 <- rexp(n,lambda0) 
 
       ### Real 
   Sreal0 <- sum(time0>Mediana0)/n 
   Sreal1 <- sum(time1>Mediana0)/n 
   RR_Real[j] <- (1-Sreal1)/(1-Sreal0) 
   OR_Real[j] <- ((1-Sreal1)/Sreal1)/((1-Sreal0)/Sreal0) 
   RD_Real[j] <- Sreal1 - Sreal0  
 
   ### Amb dades censurades 
       AddCensure1 <- AddCensure(time1,time0,lambda1,lambda0,t.recluta=0,prop.cens=prop1[i], 
     pFollow=0,tFollow=NULL,graph=FALSE,distribution="Exponential", 
     sh=NULL,sca1=NULL,sca2=NULL) 
   AddCensure0 <- AddCensure(time1,time0,lambda1,lambda0,t.recluta=0,prop.cens=prop0, 
     pFollow=0,tFollow=NULL,graph=FALSE,distribution="Exponential", 
     sh=NULL,sca1=NULL,sca2=NULL) 
 
   timeCens1 <- AddCensure1[1:n,1] 
   status1 <- AddCensure1[1:n,2] 
     timeCens0 <- AddCensure0[(n+1):(2*n),1] 
   status0 <- AddCensure0[(n+1):(2*n),2] 
 
   n0 <- sum(status0) 
       n1 <- sum(status1) 
       Scens0 <- sum(timeCens0>Mediana0 & status0==1)/n0 
   Scens1 <- sum(timeCens1>Mediana0 & status1==1)/n1 
   RR_Cens[j] <- (1-Scens1)/(1-Scens0) 
   OR_Cens[j] <- ((1-Scens1)/Scens1)/((1-Scens0)/Scens0) 
   RD_Cens[j] <- Scens1 - Scens0  
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       ### Amb dades censurades a través del HRR 
       time <- c(timeCens0,timeCens1) 
   status <- c(status0,status1) 
       times.Surv <- Surv(time,status) 
       treatment <- c(rep(0,n),rep(1,n)) 
       mod.cox2 <- coxph(times.Surv~treatment) 
   HRR <- exp(mod.cox2$coef) 
 
   SHRR0 <- 0.5 
   SHRR1 <- 0.5^HRR 
   
   RR_HRR[j] <- (1-SHRR1 )/(1-SHRR0) 
   OR_HRR[j] <- ((1-SHRR1 )/SHRR1)/((1-SHRR0)/SHRR0) 
   RD_HRR[j] <- SHRR1 - SHRR0 
   
   ### Supervivència KM + IC en Med0 
   times.survfit <- survfit(times.Surv~treatment) 
   timestreat <- times.survfit$time[(n+1):(2*n)] 
   timestreatSort <- sort(timestreat) 
   sel <- min(which(timestreat>Mediana0)) 
   
       Streat <- times.survfit$surv[(n+1):(2*n)] 
   LIStreat <- times.survfit$lower[(n+1):(2*n)] 
   LSStreat <- times.survfit$upper[(n+1):(2*n)] 
   sel2 <- min(which(Streat<0.5)) 
   cat("sel1: ",sel,"sel2:",sel2,"\n") 
   SKM[j] <- Streat[sel] 
   LISKM[j] <- LIStreat[sel] 
   LSSKM[j] <- LSStreat[sel] 
   
   ### Supervivencia HRR 
   LIHRR <- summary(mod.cox2)$conf.int[3] 
   LSHRR <- summary(mod.cox2)$conf.int[4] 
   SHRR[j] <- 0.5^HRR 
   LISHRR[j] <- 0.5^LSHRR  
   LSSHRR[j] <- 0.5^LIHRR 
   
 } 
 M[1,i] <- exp(mean(log(RR_Real))) ;   
 M[2,i] <- exp(mean(log(OR_Real))) ;  
 M[3,i] <- mean(RD_Real) 
 M[4,i] <- exp(mean(log(RR_Cens))) ;   
 M[5,i] <- exp(mean(log(OR_Cens))) ;  
 M[6,i] <- mean(RD_Cens) 
 M[7,i] <- exp(mean(log(RR_HRR)))  ;   
 M[8,i] <- exp(mean(log(OR_HRR)))  ;  
 M[9,i] <- mean(RD_HRR) 
  
   M2[1,i] <- mean(SKM)  ;  M2[2,i] <- mean(LISKM)   ; M2[3,i] <- mean(LSSKM) 








































legendLabel <- c("Theoretical or modeled RR","RR calculated with full data", 
           "RR directly calculated with censored data", 












legendLabel <- c("Theoretical or modeled OR","OR calculated with full data", 
           "OR directly calculated with censored data", 













legendLabel <- c("Theoretical or modeled DR","DR calculated with full data", 
           "DR directly calculated with censored data", 




#### Supervivència KM versus Supervivència HRR 
par(las=1,mfrow=c(1,1),lwd=2) 
plot(prop1,M2[1,],type="l",col=2,main="KM Survival vs. HRR Survival",ylim=c(0,1), 









Script 7. Script per a la realització de la Figure 20. 




BlandAltman <- function(x,y,tit="Bland-Altman",size,co,ID=NULL,limy=NULL){ 
 
 Bmean <- (x+y)/2 
 Bdif <- y-x 
 ymax <- max(abs(Bdif),na.rm=T) 
  
 plot(Bmean ,Bdif ,ylim=c(-0.1,0.1), 
      xlab=expression((theta[1]+hat(theta)[2])/2), 
      ylab=expression(hat(theta)[2]-theta[1]), 
      main=tit,pch=1,cex=size,col=co) 
 abline(h=0,lty=2) 
 mtext(expression(paste("Greater ",hat(theta)[2])),2,line= 3.5,at=0.1,adj=1,cex=0.9) 
 mtext(expression(paste("Greater ",theta[1])),2,line= 3.5,at=-0.1,adj=1,cex=0.9) 









n <- 20 
treatment <- c(rep(0,n),rep(1,n)) 
status <- rep(1,2*n) 
 
################################################################################ 
# Opció 1  
################################################################################ 
A1 <- seq(10,48,2) 
B1 <- c(rep(9,10),seq(11,29,2)) 
times1 <- c(A1,B1) 
times.Surv1 <- Surv(times1,status) 
times.survfit1 <- survfit(times.Surv1~treatment) 





# Opció 2  
################################################################################ 
A2 <- seq(10,48,2) 
B2 <- c(rep(1,10),seq(11,29,2)) 
times2 <- c(A2,B2) 
times.Surv2 <- Surv(times2,status) 
times.survfit2 <- survfit(times.Surv2~treatment) 









# Comparació entre controls 
################################################################################ 
times4 <- c(B1,B2) 
times.Surv4 <- Surv(times4,status) 
times.survfit4 <- survfit(times.Surv4~treatment) 



















# Càlcul de fita 
n <- 50 
treatment <- c(rep(0,n),rep(1,n)) 
status <- rep(1,2*n) 
Fita1 <- c() 
Fita2 <- c() 
 
for(k in 1:100){ 
 A3 <- rexp(n,0.8) 
 B3 <- rexp(n,1) 
 times3 <- c(A3,B3) 
 times.Surv3 <- Surv(times3,status) 
 times.survfit3 <- survfit(times.Surv3~treatment) 
 mod.cox3 <- coxph(times.Surv3~treatment) 
 HRR[k] <- exp(-mod.cox3$coef) 
 summary(mod.cox3) 
 
 GanaA <- 0 
 GanaB <- 0 
 Total <- n^2 
 for (i in 1:n){ 
  for (j in 1:n){ 
   if (A3[i]<B3[j]) GanaA <- GanaA+1 
  } 
 } 
 Fita1[k] <- GanaA/Total 




maxxy <- max(c(Fita1,Fita2)) 




















Script 8. Script per a la realització de la Figure 8. 
### BA graphic 
BlandAltman <- function(x,y,tit="Bland-Altman",size,co,ID=NULL,limx=NULL,limy=NULL){ 
 
 Bmean <- (x+y)/2 
 Bdif <- y-x 
 
 if (is.null(limy))  ymax <- max(abs(Bdif),na.rm=T) 
 if (!is.null(limy)) ymax <- limy 
 
 plot(Bmean ,Bdif ,ylim=c(-ymax,ymax),xlim=c(0,100),xlab="Average", 
      ylab="Difference",main=tit,pch=19,cex=size,col=co) 
 abline(h=0,lty=2,lwd=2) 
 if(!is.null(ID)) text(Bmean,Bdif,ID,pos=4,cex=0.6)  # identificador 






### Good Concordance 
x <- runif(100,0,100) 
y <- x + rnorm(100,0,0.5) 
BlandAltman(x,y,tit="Good Concordance",size=0.9,co=1,limy=2.5) 
 
### Systematic error 
x <- runif(100,0,100) 
y <- x + 0.8 +rnorm(100,0,0.5) 
BlandAltman(x,y,tit="Systematic error",size=0.9,co=1,limy=2.5) 
 
### Good correlation/Bad concordance 
x <- runif(100,0,100) 
y <- 1.02*x - 1 + rnorm(100,0,0.1) 
BlandAltman(x,y,tit="Good correlation/Bad concordance",size=0.9,co=1,limy=2.5) 
 
### Concordance dependent on the magnitude of the response 
x <- runif(100,0,100) 
y <- x + rnorm(100,0,0.02*x) 







Script 9. Script per a la realització de la Figure 9. 
library(psych) 
# Funnel-plot examples 
par(las=1,mar=c(5,6,5,0),lwd=1,cex=1.2) 
mat <- matrix(c(1,2,3),nrow=1) 
layout(mat, widths = c(0.95,0.8,0.8)) 
###################################### Sin sesgo  ############################################### 
plot(NULL,xlim=c(0.1,10),ylim=c(0,15),log="x",xlab="Effect",ylab=expression(frac(1,SE)), 
    main="Non publication bias",cex.lab=1.2) 
abline(v=1,lty=2) 
x <- c() 
y <- c() 
 
for (i in 1:100){ 
  y[i] <- rexp(1,0.2) 
  x[i] <- exp(rnorm(1,0,2/y[i])) 
  points(x[i],y[i],cex=1.2) 
} 
###################################### Con sesgo tipo I ######################################### 
par(mar=c(5,0.5,5,0)) 
plot(NULL,xlim=c(0.1,10),ylim=c(0,15),log="x",xlab="Effect",ylab=expression(frac(1,SE)), 
    main="Bilateral publication bias",cex.lab=1.2,yaxt="n") 
abline(v=1,lty=2) 
x <- c() 
y <- c() 
npoints <- 0 
 
while (npoints<100){ 
  Y <- rexp(1,0.2) 
  X <- exp(rnorm(1,0,2/Y)) 
  if (Y>7.5 | (Y<=7.5 & (X>3 | X<1/3))){ 
    npoints <- npoints +1 
    points(X,Y,cex=1.2) 
    y[npoints] <- Y 
    X[npoints] <- X 
  } 
  else{ 
    probPrint <- runif(1) 
    if (probPrint<0.04){ 
          npoints <- npoints +1 
          points(X,Y,cex=1.2) 
          y[npoints] <- Y 
          x[npoints] <- X 
    } 
  } 
} 
###################################### Con sesgo tipo II ######################################### 
par(mar=c(5,0.5,5,1)) 
plot(NULL,xlim=c(0.1,10),ylim=c(0,15),log="x",xlab="Effect",ylab=expression(frac(1,SE)), 
    main="Unilateral publication bias",cex.lab=1.2,yaxt="n") 
abline(v=1,lty=2) 
x <- c() 
y <- c() 
npoints <- 0 
 
while (npoints<100){ 
  Y <- rexp(1,0.2) 
  X <- exp(rnorm(1,0,2/Y)) 
  if (Y>7.5 | (Y<=7.5 & X>3)){ 
    npoints <- npoints +1 
    points(X,Y,cex=1.2) 
    y[npoints] <- Y 
    X[npoints] <- X 
  } 
  else{ 
    probPrint <- runif(1) 
    if (probPrint<0.04){ 
          npoints <- npoints +1 
          points(X,Y,cex=1.2) 
          y[npoints] <- Y 
          x[npoints] <- X 
    } 




Script 10. Script per a la realització de les figures de l'Annexe II. 
########################################################################## 




xe <- seq(0,8,0.01) 
n <- length(xe) 
 
lambda1 <- 1      # Azul 
lambda2 <- 0.4    # Rojo 
 
distribucion_e1 <- pexp(xe, lambda1) 
distribucion_e2 <- pexp(xe, lambda2) 
 
supervivencia_e1 <- 1-distribucion_e1 
supervivencia_e2 <- 1-distribucion_e2 
 
densidad_e1 <- dexp(xe, lambda1) 
densidad_e2 <- dexp(xe, lambda2) 
 
riesgo_e1 <- densidad_e1/supervivencia_e1 
riesgo_e2 <- densidad_e2/supervivencia_e2 
 
riesgoacum_e1 <- cumsum(riesgo_e1) 
riesgoacum_e2 <- cumsum(riesgo_e2) 
 
ymin <- min(c(supervivencia_e1,supervivencia_e2,densidad_e1,densidad_e1, 
riesgo_e1,riesgo_e2,riesgoacum_e1,riesgoacum_e2)) 
 









plot(xe,supervivencia_e1,type='l', xlab='Temps',ylab="S", col='blue') 
lines(xe,supervivencia_e2,col="red") 
ytext <- max(c(supervivencia_e1,supervivencia_e2)) 
#text(6,0.9,paste("HRR =", round(lambda1/lambda2,2)),adj=1,cex=0.9) 













#       WEIBULL 
########################################################################## 
 
aux <- 6 
x_w1 <- seq(0.01,aux,0.01) 
n <- length(x_w1) 
k1 <- 0.75          # Para HRR constante k1=k2 
k2 <- 1.15 
scale1 <- 1.63 
HRR <- 1/0.9 
# scale2 <- (HRR)^(1/k1)*scale1 
scale2 <- 1.89 
 
distribucion_w1 <- pweibull(x_w1, shape=k1, scale = scale1, log = FALSE) 
distribucion_w2 <- pweibull(x_w1, shape=k2, scale = scale2, log = FALSE) 
 
supervivencia_w1 <- 1-distribucion_w1 
supervivencia_w2 <- 1-distribucion_w2 
 
densidad_w1 <- dweibull(x_w1, shape=k1, scale = scale1, log = FALSE) 
densidad_w2 <- dweibull(x_w1, shape=k2, scale = scale2, log = FALSE) 
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riesgo_w1 <- densidad_w1/supervivencia_w1 
riesgo_w2 <- densidad_w2/supervivencia_w2 
 
riesgoacum_w1 <- cumsum(riesgo_w1) 












#text(aux,0.9,paste("HRR =", round((scale2/scale1)^k1,2)),adj=1,cex=0.9) 





ymin <- min(c(riesgo_w1,riesgo_w2)) 
ymax <- max(c(riesgo_w1,riesgo_w2)) 









(mean1 <- scale1*gamma(1+1/k1)) 
(mean2 <- scale2*gamma(1+1/k2)) 
 
(med1 <- scale1*log(2)^(1/k1)) 




#       LOG-LOGISTICA 
########################################################################## 
library(actuar) 
aux <- 6 
xllg <- seq(0,aux,0.01)[-1] 
k1 <- 1.5 
k2 <- 1.5 
scale1 <- 0.63 
scale2 <- 1.63 
 
distribucionllg1 <- pllogis(xllg, shape=k1, scale = scale1, log = FALSE) 
distribucionllg2 <- pllogis(xllg, shape=k2, scale = scale2, log = FALSE) 
 
 
supervivenciallg1 <- 1-distribucionllg1 
supervivenciallg2 <- 1-distribucionllg2 
 
densidadllg1 <- dllogis(xllg, shape=k1, scale = scale1, log = FALSE) 
densidadllg2 <- dllogis(xllg, shape=k2, scale = scale2, log = FALSE) 
 
riesgollg1 <- densidadllg1/supervivenciallg1 
riesgollg2 <- densidadllg2/supervivenciallg2 
 
riesgoacumllg1 <- cumsum(riesgollg1) 



























# Esperanza aprox 
(mean1 <- sum(0.01*supervivenciallg1)) 
(mean2 <- sum(0.01*supervivenciallg2)) 
 
(med1 <- scale1) 
(med2 <- scale2) 






Script 11. Script per a la realització de les figures de l'Annexe IX. 
###################################################################### 
# Script para simular gráfico de BA con exponencial y Weibull 














### Lectura ########################################## 
setwd('E:\\TFM\\RecercaHRRvsMediana') 
NEJM <- read.csv2('NEJM3.csv',header=TRUE,dec='.') 
names(NEJM) 
 
### Paràmetres Simulació 
nsim <- 1 
opc11 <- 1      # 1=Todo ; 2=OS ; 3=PFS 
opc2 <- 2       # 1=Todos los datos 2=Sólo ECA's 
opc3 <- 1       # 1=BA 2= gráfico JAG 
 
### Enmagatzemar resultats 
concordancia <- c() 
SD <- c() 
M <- matrix(NA,nrow=3,ncol=4) 
colnames(M) <- c("concordanceExp","SDExp","concordanceWeib","SDWeib") 
rownames(M) <- c("global","OS","PFS") 
 
################################## Lectura ########################################## 
for (opc1 in opc11){ 
   
  ### Dades 
  if(opc2==1) dades1 <- NEJM 
  if(opc2==2) dades1 <- subset(NEJM,NEJM$CT=="Yes") 
  if(opc2==1) filename <- "Alldata" 
  if(opc2==2) filename <- "Partialdata" 
   
  if(opc1==1) dades <- dades1 
  if(opc1==2) dades <- subset(dades1,dades1$Type=="OS") 
  if(opc1==3) dades <- subset(dades1,dades1$Type=="PFS") 
  if(opc1==1) filename <- paste(filename,"AllResponse.txt",sep="") 
  if(opc1==2) filename <- paste(filename,"OS.txt",sep="") 
  if(opc1==3) filename <- paste(filename,"PFS.txt",sep="") 
  
   
  ######################################################################## 
  # 
  # Exponencial 
  # 
  ######################################################################## 
 
  NumMeasures <- dim(dades)[1]                  # Número de casos 
   
  # Proporció de censures 
  NEJMwithEvents <- subset(dades,!is.na(dades$E)) 
  pc2 <- 1- with(NEJMwithEvents,sum(E)/sum(N))  #Proporció de censures promig 
  pc1 <- 1-dades$E/dades$N                      #Proporció de censures 
  prop.cens <- ifelse(!is.na(dades$E),pc1,pc2) 
   
  # Paràmetres 
  lambda1 <- 1 
  lambda2 <- dades$HRR 
  t.recluta <- 0 
  prop.censFollow <- 0 
   
  n1 <- dades$NC 
  n2 <- dades$NT 
   
  #if (opc3==1) {win.graph() ; par(las=1,mfrow=c(2,2),mar=c(7,7,4,4))} 
  
 111
    if (opc3==2){ 
    win.graph() 
    par(mfrow=c(1,1),las=1,mar=c(8,6,3,3)) 
    lim <- 1.2 
    plot(NULL,xlim=c(-lim,lim),ylim=c(-lim,lim),main="Exponencial", 
          xlab=expression(log~bgroup("(",frac(MR,HRR^-1),")")), 
    ylab=expression(log~hat(bgroup("(",frac(MR,HRR^-1),")"))), cex.lab=0.7) 
  }         
   
   
propMRremove <- c()   
for (j in 1:nsim){ 
    ### Inicialitzar vectors 
    MR <- c() 
    HRR <- c() 
    size <- c() 
 
    for (i in 1:NumMeasures){ 
   
        time1 <- rexp(n1[i],lambda1) 
        time2 <- rexp(n2[i],lambda2[i]) 
   
        AC <- AddCensure(time1,time2,lambda1,lambda2[i],t.recluta, 
  prop.cens[i],prop.censFollow,tFollow=NULL,graph=FALSE) 
        times <- AC[,1]   # Temps: Fins n són del grup control y a partir de (n+1) del tractat 
        status <- AC[,2]  # Censures: Fins n són del grup control y a partir de (n+1) del tractat   
        treatment <- as.factor(c(rep("Control",n1[i]),rep("Treated",n2[i]))) 
        time.Surv <- Surv(times,status)               # Tiempos en un vector con su estado 
         
        MR[i] <- ObtenerMR(time.Surv,treatment) 
         
        mod.cox <- coxph(time.Surv~treatment) 
        HRR[i] <- exp(coef(mod.cox)) 
        size[i] <- 1/sqrt(mod.cox$var) 
 
        ### Gráfico JAG 
        if (opc3==2){ 
          greycol <- as.character(100-min(round((size[i])*10),100)) 
          co <- paste("grey",greycol,sep="") 
          points(log(dades$MedRat[i]/dades$HRR[i]),log(MR[i]/HRR[i]),pch=19,col=co,cex=0.7) 
        } 
    } 
    EliminarNAs(variable=MR,MR,HRR,size) 
     
   
    if (opc3==1){ 
      xymin <<- min(c(HRR,MR),na.rm=T) ; xymax <<- max(c(HRR,MR),na.rm=T)  
      BlandAltman(log(HRR),log(MR),"",1/8*size,1,ID=NULL,limx=c(-1.5,0.5),limy=3) 
      AxisBlandAltman(MR,HRR,EE=1/size,Type=ifelse(opc1==1,"Global",ifelse(opc1==2,"OS","PFS"))) 
    } 
     
    # Iteración 
    cat('Exp',opc1,opc2,'--> ite:',j,"\n") 
     
    # Concordancia 
    concordancia[j] <- CalculoLin(MR,HRR,size) 
     
     
    # SD 
    SD[j] <- sd(log(MR)-log(HRR)) 
    cat("SD:",SD[j],"\n") 
   
     
  } 
  M[opc1,1:2] <- c(mean(concordancia),mean(SD)) 
   
  filename2 <- paste("Exp",filename,sep="") 
  cat(filename2,"Concordancia: ",mean(concordancia)) 
  cat(filename2,"SD: ",mean(SD)) 
  write.table(cbind(concordancia,SD), file = filename2, sep = "\t", row.names = FALSE) 
 









  ######################################################################## 
  # 
  # Weibull 
  # 
  ######################################################################## 
 
     
  # Proporción de censuras 
  NEJMwithEvents <- subset(dades,!is.na(dades$E)) 
  pc2 <- 1- with(NEJMwithEvents,sum(E)/sum(N))  #Proporció de censures promig 
  pc1 <- 1-dades$E/dades$N                      #Proporción de censuras 
  prop.censa <- ifelse(!is.na(dades$E),pc1,pc2) 
   
  # Praàmetres 
  t.recluta <- 0 
  prop.censFollow <- 0 
  n1a <- dades$NC 
  n2a <- dades$NT 
   
  # Càlcul paràmetres de la Weibull  
  ka <- with(dades,log(HRR)/log(MedRat))                                 
  rho2a <- with(dades,ifelse(HRR_Adj<0,MedianC,MedianT))/(log(2)^(1/ka))  
  rho1a <- with(dades,ifelse(HRR_Adj<0,MedianT,MedianC))/(log(2)^(1/ka)) 
   
  # Elimina las k's que son Na, negatives o infinit 
  elim1 <- which(is.na(ka) | ka+1==ka | ka<0)  
  k <- ka[-elim1] 
  rho1 <- rho1a[-elim1]; rho2 <- rho2a[-elim1] 
  n1 <- n1a[-elim1]; n2 <- n2a[-elim1] 
  prop.cens <- prop.censa[-elim1] 
   
   
  NumMeasures <- length(k) 
   
   
  #if (opc3==1) {win.graph() ; par(las=1,mfrow=c(2,2),mar=c(7,7,4,4))} 
   
  ### 3 lineas para gráfico JAG 
  if (opc3==2){   
    win.graph() 
    par(mfrow=c(1,1),las=1,mar=c(8,6,3,3)) 
    lim <- 1.2 
    plot(NULL,xlim=c(-lim,lim),ylim=c(-lim,lim),main="Weibull", 
           xlab=expression(log~bgroup("(",frac(MR,HRR^-1),")")), 
  ylab=expression(log~hat(bgroup("(",frac(MR,HRR^-1),")"))),cex.lab=0.7)   
  } 
   
  for (j in 1:nsim){ 
    ### Inicializar vectores 
    MR <- c() 
    HRR <- c() 
    size <- c() 
    for (i in 1:NumMeasures){ 
        time1 <- rweibull(n1[i],k[i],rho1[i]) 
        time2 <- rweibull(n2[i],k[i],rho2[i]) 
   
        AC <- AddCensure(time1,time2,lambda1,lambda2[i],t.recluta,prop.cens[i],prop.censFollow, 
   tFollow=NULL,graph=FALSE,"Weibull",sh=k[i],sca1=rho1[i],sca2=rho2[i]) 
        times <- AC[,1]  # Temps: Fins n són del grup control y a partir de (n+1) del tractat 
        status <- AC[,2]  # Censures: Fins n són del grup control y a partir de (n+1) del tractat   
        treatment <- as.factor(c(rep("Control",n1[i]),rep("Treated",n2[i]))) 
        time.Surv <- Surv(times,status)                        
        MR[i] <- ObtenerMR(time.Surv,treatment) 
        mod.cox <- coxph(time.Surv~treatment) 
        HRR[i] <- exp(coef(mod.cox)) 
        size[i] <- 1/sqrt(mod.cox$var) 
         
        ### Gráfico JAG 
        if (opc3==2){         
          greycol <- as.character(100-min(round((size[i])*10),100)) 
          co <- paste("grey",greycol,sep="") 
          points(log(dades$MedRat[i]/dades$HRR[i]),log(MR[i]/HRR[i]),pch=19,col=co,cex=0.7)         
        } 
    } 
   
    propMRremove[j] <- EliminarNAs(variable=MR,MR,HRR,size) 
 
    if (opc3==1){         
      xymin <<- min(c(HRR,MR),na.rm=T) ; xymax <<- max(c(HRR,MR),na.rm=T) 
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      BlandAltman(log(HRR),log(MR),"",1/8*size,1,ID=NULL,limx=c(-1.5,1.5),limy=3) 
      AxisBlandAltman(MR,HRR,EE=1/size,Type=ifelse(opc1==1,"Global",ifelse(opc1==2,"OS","PFS"))) 
    }     
  
    # SD 
    SD[j] <- sd(log(MR)-log(HRR)) 
    cat("SD:",SD[j],"\n") 
   
  } 
  M[opc1,3:4] <- c(mean(concordancia),mean(SD)) 
   
   
  filename2 <- paste("Weib",filename,sep="") 
  cat(filename2,"Concordancia: ",mean(concordancia)) 
  cat(filename2,"SD: ",mean(SD)) 
  write.table(cbind(concordancia,SD), file = filename2, sep = "\t", row.names = FALSE) 





# Antes de leer los datos, hay que copiar los ficheros en el directorio 
# E:\\TFM\\RecercaHRRvsMediana\\Concordancias simuladas 
 
### Leer datos 
setwd('E:\\TFM\\RecercaHRRvsMediana\\Concordancias simuladas') 
EAA <- read.table('ExpPartialdataAllResponse.txt',header=T) 
EAOS <- read.table('ExpPartialdataOS.txt',header=T) 
EAPFS <- read.table('ExpPartialdataPFS.txt',header=T) 
 
WAA <- read.table('WeibPartialdataAllResponse.txt',header=T) 
WAOS <- read.table('WeibPartialdataOS.txt',header=T) 
WAPFS <- read.table('WeibPartialdataPFS.txt',header=T) 
 
A <- cbind(EAA,EAOS,EAPFS,WAA,WAOS,WAPFS) 
colnames(A) <- paste(rep(c("Concordance","SD"),6),c(rep("Exp",6),rep("Weib",6)), 





Script 12. Funcions usades en l'script 11. 
 
ObtenerMR <- function(time.Surv,treatment){ 
      time.survfit <- survfit(time.Surv~treatment)  # Cálculo de Kaplan-Meier 
      median1 <- summary(time.survfit)$table["treatment=Control","median"] 
      median2 <- summary(time.survfit)$table["treatment=Treated","median"] 
      MR <- median1/median2 






EliminarNAs <- function(variable,MR,HRR,size){ 
  l <- length(variable) 
  elim <<- which(is.na(variable)) 
  if(length(elim)!=0){ 
    MR <<- MR[-elim] 
    HRR <<- HRR[-elim] 
    size <<- size[-elim] 
  } 







CalculoLin <- function(MR,HRR,size){ 
  dades2 <- data.frame(cbind(MR,HRR)) 
  colnames(dades2) <- c("MedRat","HRR") 
  concordancia <- LinWeigth(dades2,1/8*size)[2] 
  cat("Coeficiente de Linn ponderado:",concordancia,"\n") 





Script 13. Funcions per generar les censures. 
#################################################################### 
# Use this fuction to add censure to times with a expected proportion  
# of not random censures in each group and 
# exact proportion of censures for end of follow-up 
# time1, time2: times of events 
# lambda1,lambda2: parameters of exponential 
# t.recluta: recruitment time 
# prop.cens: proportion of expected censures during the follow-up 
# pFollow: proportion of exact censures due to finsih of study 
# (if tFollow is not NULL, then this parameter is ignored) 
# tFollow: time of follow-up 
# graph: if TRUE, then print the process of censure (recommended for small sample sizes) 
# 
# Return a matrix with  times in first colum and censures in second colum: 
# (1: not censured, 0:censured) 
# This function calls the fuctions below 
#################################################################### 
 
AddCensure <- function (time1,time2,lambda1,lambda2,t.recluta,prop.cens,pFollow=NULL,tFollow=NULL, 
    graph=FALSE,distribution="Exponential",sh=NULL,sca1=NULL,sca2=NULL){ 
    # Tiempos originales (time) 
    time <- c(time1,time2) 
 
    ### Tamaños de muestra 
    n1 <- length(time1) 
    n2 <- length(time2) 
    n <- n1+n2 
 
    # Añadir tiempos de censura Uniforme entre [0,Tmax] (timeb).  
    # Primero se debe calcular Tmax1 y Tmax2 (17/10/10 de la llibreta) 
    if (distribution=="Exponential") timeAux <- CensuraUnif2(time1,time2,lambda1,lambda2,prop.cens) 
    if (distribution=="Weibull") timeAux <- CensuraWeibull(time1,time2,sh,sca1,sca2,prop.cens)     
    time1a <- timeAux[[1]] 
    time2a <- timeAux[[2]] 
    timea <- c(time1a,time2a) 
 
    # Tiempos con periodo de reclutamiento  (timeb) 
    timeAux <- CensuraRecruit(time1a,time2a,t.recluta) 
    time1b <- timeAux[[1]] 
    time2b <- timeAux[[2]] 
    timeb <- c(time1b,time2b)         # Se añade el tiempo de reclutamiento a los tiempos generados 
 
    # Tiempos con finalización del estudio  (timec) 
    timec <- CensuraEnd(timeb,pFollow,tFollow,t.recluta) 
     
    # Trasladamos los tiempos al cero (timed) 
    timed <- timec-entry 
 
    # Incluir censuras en la variable e-status 
    status <- rep(1,n) 
    for (i in 1:n){ 
        if(timec[i]==tFollowAux | timea[i]==Cens[i]){status[i] <- 0} 
    } 
 
    ####################################### Graphics ######################################### 
    if (graph){ 
    ### Printar resultados 
    PrintSet(time1,time2,time1a,time2a,time1b,time2b,tFollowAux,status,Cens1,Cens2, 
  n1,n2,lambda2,prop.cens,pFollow) 
 
     CensGraphics(time1,time2,timea,timeb,timec,timed,tFollowAux,t.recluta,n,n1,n2, 
   lambda1,lambda2,Cens,Cens1,Cens2,prop.cens,pFollow,Tmax) 
    } 














# Para 2 conjuntos de tiempo cualesquiera time1 y time2 genera dos conjuntos de  
# tiempos time1a y time2a censurados uniformemente entre 0 y Tmax 
################################################################################ 
 
CensuraUnif <- function(time1,time2,Tmax){ 
 
    n1 <- length(time1) 
    n2 <- length(time2) 
 
    Cens1 <<- runif(n1,0,Tmax) 
    Cens2 <<- runif(n2,0,Tmax) 
    Cens <<- c(Cens1,Cens2) 
 
    time1a <- pmin(time1,Cens1) 
    time2a <- pmin(time2,Cens2) 
 





# Para 2 conjuntos de tiempo exponenciales time1 y time2 con tasas lambda1 y 
# lambda2 genera dos conjuntos de tiempos time1a y time2a censurados uniformemente 
# con una proporción de censuras globales ESPERADAS de prop.cens. 
# Si los tiempos no son exponenciales NO funciona 
################################################################################ 
 
CensuraUnif2 <- function(time1,time2,lambda1,lambda2,prop.cens){ 
 
    n1 <- length(time1) 
    n2 <- length(time2) 
 
    if (prop.cens!=0){ 
       
      f <- function (x,prop.cens,lambda1,lambda2,n1,n2) { 
        term1 <- n1*(exp(-lambda1*x)-1)/(lambda1*x) 
        term2 <- n2*(exp(-lambda2*x)-1)/(lambda2*x) 
        term3 <- (n1+n2)*prop.cens 
        sol <- term1+term2+term3 
        return(sol) 
      } 
   
      Tmax <<- uniroot(f,interval=c(0.01,500),tol=0.0001,prop.cens=prop.cens, 
 lambda1=lambda1,lambda2=lambda2,n1=n1,n2=n2)$root 
   
      Cens1 <<- runif(n1,0,Tmax) 
      Cens2 <<- runif(n2,0,Tmax) 
      Cens <<- c(Cens1,Cens2) 
   
      time1a <- pmin(time1,Cens1) 
      time2a <- pmin(time2,Cens2) 
    } 
     
    if (prop.cens==0){ 
       
      Tmax <<- 10^20 
   
      Cens1 <<- rep(Tmax,n1) 
      Cens2 <<- rep(Tmax,n2) 
      Cens <<- c(Cens1,Cens2) 
   
      time1a <- time1 
      time2a <- time2 
    } 
     














# Para 2 conjuntos de tiempo Weibull time1 y time2 con tasas lambda1 y 
# lambda2 genera dos conjuntos de tiempos time1a y time2a censurados uniformemente 
# con una proporción de censuras globales ESPERADAS de prop.cens. 
# Si los tiempos no son Weibull NO funciona 
################################################################################ 
 
CensuraWeibull <- function(time1,time2,sh,sca1,sca2,prop.cens){ 
 
    n1 <- length(time1) 
    n2 <- length(time2) 
 
    if (prop.cens!=0){                                         # Libreta 29/4/11 
      f1 <- function(y,sh,sca) exp(-(y/sca)^sh) 
      f <- function (x,prop.cens,sh,sca1,sca2,n1,n2) { 
        term1 <- n1*integrate(f1,0,x,sh,sca1)$value 
        term2 <- n2*integrate(f1,0,x,sh,sca2)$value 
        term3 <- (n1+n2)*prop.cens*x 
        sol <- term1+term2-term3 
        return(sol) 
      } 
   
      Tmax <<- uniroot(f,interval=c(0.01,10^5),tol=0.0001,prop.cens=prop.cens, 
  sh=sh,sca1=sca1,sca2=sca2,n1=n1,n2=n2)$root 
   
      Cens1 <<- runif(n1,0,Tmax) 
      Cens2 <<- runif(n2,0,Tmax) 
      Cens <<- c(Cens1,Cens2) 
   
      time1a <- pmin(time1,Cens1) 
      time2a <- pmin(time2,Cens2) 
    } 
     
    if (prop.cens==0){ 
       
      Tmax <<- 10^20 
   
      Cens1 <<- rep(Tmax,n1) 
      Cens2 <<- rep(Tmax,n2) 
      Cens <<- c(Cens1,Cens2) 
   
      time1a <- time1 
      time2a <- time2 
    } 
    # Aux <<- cbind(time1,time1a,Cens1,time2,time2a,Cens2) 





# Para 2 conjuntos de tiempo cualesquiera time1 y time2 genera dos conjuntos de 
# tiempos time1b y time2b desplazados a la derecha un tiempo de reclutamiento 
# entre 0 y t.recluta 
# Esta función solo tiene sentido usarla si luego se va añadir censura por 




CensuraRecruit <- function(time1a,time2a,t.recluta){ 
    n1 <- length(time1a) 
    n2 <- length(time2a) 
 
    entry1 <<- runif(n1,0,t.recluta)   # tiempos de entrada en el estudio  (grupo1) 
    entry2 <<- runif(n2,0,t.recluta)   # tiempos de entrada en el estudio (grupo2) 
    entry <<- c(entry1,entry2) 
    time1b <- time1a+entry1 
    time2b <- time2a+entry2 














# Para un conjunto de tiempo cualesquiera time, 
# 1. Si tFollow es NULL censura una proporción pFollow de tiempos por finalización de estudio. 
# 2. Si tFollow no es NULL censura tosos los tiempos superiores a tFollow 
# Retorna timec, que son los tiempos censurados. 
# Se repestará pFollow siempre que sto no suponga que la finalización del estudio 




CensuraEnd <- function(time,pFollow,tFollow,t.recluta){ 
 
    if(!is.null(tFollow)){ 
      tFollowAux <<- tFollow 
      if (tFollow<t.recluta){ 
        print("El tiempo de seguimiento debe ser mayor que el tiempo de reclutamiento") 
      } 
      if (tFollow>=t.recluta){ 
        timec <- pmin(time,tFollow) 
        return(timec) 
      } 
     
    } 
 
    if(is.null(tFollow)){ 
      if(pFollow!=0){ 
        n <- length(time) 
        timebAux <-  sort(time,decreasing=TRUE) 
        ncens <- ceiling(pFollow*n) 
        tFollow0 <- ifelse(ncens!=0, mean(timebAux[ncens:(ncens+1)]),max(time))        
        tFollowAux <<- pmax(tFollow0,t.recluta) 
        timec <- pmin(time,tFollowAux) 
        return(timec) 
      } 
      if(pFollow==0){ 
        tFollowAux <<- 10^20 
        return(time) 
      } 








PrintSet <- function(time1,time2,time1a,time2a,time1b,time2b,tFollow, 
  status,Cens1,Cens2,n1,n2,lambda2,prop.cens,pFollow){ 
    timeb <- c(time1b,time2b) 
    cat('----------------------------------------------------------------------\n') 
    cat("lambda 1=",lambda1,"lambda 2=",lambda2,"Expected cens during study=", 
  prop.cens,"Exact cens End study=",pFollow,"\n") 
    cat("Proporción de censuras en grupo 1 uniformes 
 (antes añadir cens por fin estudio):",sum(time1>Cens1)/n1,"\n") 
    cat("Proporción de censuras en grupo 2 uniformes 
 (antes añadir cens por fin estudio):",sum(time2>Cens2)/n2,"\n") 
    cat("Proporción de censuras en grupo 1 uniformes:", 
 sum(time1a!=time1 & time1b<tFollow)/n1,"\n")       
    cat("Proporción de censuras en grupo 2 uniformes:",sum(time2a!=time2 & time2b<tFollow)/n2,"\n") 
    cat("Proporción de censuras por fin de estudio:",sum(timeb>tFollow)/n,"\n") 




























CensGraphics <- function(time1,time2,timea,timeb,timec,timed,tFollow,t.recluta, 
  n,n1,n2,lambda1,lambda2,Cens,Cens1,Cens2,prop.cens,pFollow,Tmax){ 
 
      time <- c(time1,time2) 
 
      ### Tiempo máximo para los gráficos 
      xmax <- max(c(time1,time2,timea,timeb,timec)) 
 
      par(mfrow=c(3,2),las=1,mar=c(4,2,3,1)) 
 
      # Información de la simulación 
      plot(NULL,xlim=c(0,xmax),ylim=c(0,n),xlab="",ylab="",xaxt="n",yaxt="n", 
        main="Simulation Information") 
      h <- n-1                       # altura texto 
      s <- (n-2)/8 
      text(xmax/3,h,paste("Size Control =",n1),adj=0,cex=1.2) 
      text(xmax/3,h-s,paste("Size Treated =",n2),adj=0,cex=1.2) 
      text(xmax/3,h-2*s,paste("Lambda Control =",lambda1),adj=0,cex=1.2) 
      text(xmax/3,h-3*s,paste("Lambda Treated =",lambda2),adj=0,cex=1.2) 
      text(xmax/3,h-4*s,paste("Recruitment time =",t.recluta),adj=0,cex=1.2) 
      text(xmax/3,h-5*s,paste("Prop censures Control=",round(sum(time1>Cens1)/n1,2)),adj=0,cex=1.2) 
      text(xmax/3,h-6*s,paste("Prop censures Treated=",round(sum(time2>Cens2)/n2,2)),adj=0,cex=1.2) 
      text(xmax/3,h-7*s,paste("Prop censures end study(Nominal) =",round(sum(timeb>tFollow)/n,2), 
  "(",pFollow,")"),adj=0,cex=1.2) 
 
 
      # Tiempos originales 
 
      plot(NULL,xlim=c(0,xmax),ylim=c(0,n),xlab="Time",ylab="Individual", 
        main=paste("Original Times: Exp(",lambda2,") and Exp(",lambda1,")",sep="")) 
      for(i in 1:n){ 
        co <- ifelse(i<=n1,1,2) 
        segments(0,i,time[i],i,col=co) 
      } 
 
      # Añadir tiempos de censura Uniforme entre [0,Tmax] 
      tit1 <- paste("Uniform censure in [0,",round(Tmax,1),"]",sep="") 
      tit2 <- "Without censure" 
      tit <- ifelse(prop.cens==0,tit2,tit1) 
      plot(NULL,xlim=c(0,xmax),ylim=c(0,n),xlab="Time",ylab="Individual",main=tit) 
      for(i in 1:n){ 
        co <- ifelse(i<=n1,1,2) 
        segments(0,i,timea[i],i,col=co) 
        if(i<=n1 & timea[i]==Cens[i]){points(timea[i],i,col=1,pch=3)} 
        if(i>n1 & timea[i]==Cens[i]){points(timea[i],i,col=2,pch=3)} 
      } 
 
      # Tiempos con periodo de reclutamiento 
      plot(NULL,xlim=c(0,xmax),ylim=c(0,n),xlab="Time",ylab="Individual", 
        main=paste("Recluitment Time =",t.recluta)) 
      for(i in 1:n){ 
        co <- ifelse(i<=n1,1,2) 
        segments(entry[i],i,timeb[i],i,col=co) 
        if(timea[i]==Cens[i]){points(timeb[i],i,col=co,pch=3)} 
      } 
      abline(v=t.recluta,lty=2) 
 
      # Tiempos con finalización del estudio 
      tit1 <- paste("End study time =",round(tFollow,1)) 
      tit2 <- "Without end time of study" 
      tit <- ifelse(pFollow==0,tit2,tit1) 
      plot(NULL,xlim=c(0,xmax),ylim=c(0,n),xlab="Time",ylab="Individual",main=tit) 
      for(i in 1:n){ 
        co <- ifelse(i<=n1,1,2) 
        segments(entry[i],i,timec[i],i,col=co) 
        if(timec[i]==tFollow){points(timec[i],i,col=co,pch=4)} 
        if(timec[i]!=tFollow & timea[i]==Cens[i]){points(timec[i],i,col=co,pch=3)} 
      } 
      abline(v=c(t.recluta,tFollow),lty=2) 
 
      # Trasladamos los tiempos al origen 
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      plot(NULL,xlim=c(0,xmax),ylim=c(0,n),xlab="Time",ylab="Individual", 
        main="Translate to zero") 
      for(i in 1:n){ 
        co <- ifelse(i<=n1,1,2) 
        segments(0,i,timed[i],i,col=co) 
        if(timec[i]==tFollow){points(timed[i],i,col=co,pch=4)} 
        if(timec[i]!=tFollow & timea[i]==Cens[i]){points(timea[i],i,col=co,pch=3)} 
      } 
      win.graph() 





# Hace el gráfico de censuras contra el tiempo 
# No esta adaptado para hacer gráficos con tiempos de cualquier magnitud 
#################################################### 
 
CensVsTime <- function(n1,n2,Cens,time){ 
    par(mfrow=c(1,1)) 
    co <- c(rep(1,n1),rep(2,n2)) 
    pc <- ifelse(Cens>time,19,1) 
    maxT <- max(time) 
    maxC <- max(Cens) 
    ma <- max(maxT,maxC) 
    plot(time,Cens,col=co,xlab="Tiempos supervivencia",ylab="Tiempos de Censura", 
          xlim=c(0,ma),ylim=c(0,ma),pch=pc) 
    abline(0,1,lty=2,lwd=2) 
 
    p <- c() 
    M <- cbind(time,Cens) 
    maI <- floor(maxT) 
    for(i in 1:maI){ 
      Maux <- as.matrix(M[which(time<i & time>=(i-1)),],byrow=TRUE) 
      total <- dim(Maux)[1] 
      p[i] <- sum(Maux[,1]>Maux[,2])/total 
      print(i) 
      print(total) 
      print(sum(Maux[,1]>Maux[,2])) 
      abline(v=i,lty=2) 
      text(i-0.5,0.9*ma,round(p[i],2),cex=0.8,font=2) 
      text(ma/2,ma,"Proporción de censuras",adj=0.5,font=2) 





Durant aquests mesos són diverses les persones que d'una manera directa o indirecta han contribuït 
a que pogués presentar aquest projecte de fi de carrera. A tots ells els hi vull agrair la seva 
col·laboració desinteresada. 
En primer lloc, vull agrair als meus tutors de projecte, els professors Erik Cobo i José Antonio 
González, la seva dedicació a aquesta recerca. Les moltíssimes hores que han invertit crec que han 
servit per obtenir un bon resultat i han forjat el meu aprenentatge sobre la matèria. També vull 
destacar l'autonomia de decisions que m'han confiat 
Per altra banda, vull donar les gràcies a la professora Lupe Gomezper haver-me aconsellat i guiat 
sobre diversos aspectes de la memòria. 
Gràcies a tota la gent del departament que, en algun moment o altra els hi fet consultes puntuals 
sobre temes tènics i altres que no tant. 
També agraeixo a la Universitat Politècnica de Catalunya el haver-me ofert suport econòmic a 
través del projecte CERMET. 
Finalment, però no menys important, vull agrair a la Pilar i a l'Iker l'empenta anímica que em donen 
dia rera dia que fa que tot sigui més fàcil. 
Considero que en aquest projecte totes les persones mencionades han participat en més o menys 
mesura i a ells va dedicada aquesta memòria. 
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